{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T07:13:30Z","timestamp":1794381210502,"version":"4.9.0"},"publisher-location":"Berlin, Heidelberg","reference-count":320,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642134425","type":"print"},{"value":"9783642134432","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011]]},"DOI":"10.1007\/978-3-642-13443-2_3","type":"book-chapter","created":{"date-parts":[[2010,9,21]],"date-time":"2010-09-21T10:25:08Z","timestamp":1285064708000},"page":"33-91","source":"Crossref","is-referenced-by-count":207,"title":["Pharmacokinetics and Metabolism of Natural Methylxanthines in Animal and Man"],"prefix":"10.1007","author":[{"given":"Maurice J.","family":"Arnaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,19]]},"reference":[{"issue":"4","key":"3_CR1_3","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3109\/00498259309057033","volume":"23","author":"F Abdi","year":"1993","unstructured":"Abdi F, Pollard I, Wilkinson J (1993) Placental transfer and foetal disposition of caffeine and its immediate metabolites in the 20-day pregnant rat: function of dose. Xenobiotica 23(4):449\u2013456","journal-title":"Xenobiotica"},{"issue":"4","key":"3_CR2_3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/BF00544361","volume":"28","author":"D Abernethy","year":"1985","unstructured":"Abernethy D, Todd E (1985) Impairment of caffeine clearance by chronic use of low-dose estrogen-containing oral contraceptives. Eur J Clin Pharmacol 28(4):425\u2013428","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"3_CR3_3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1365-2125.1985.tb02799.x","volume":"20","author":"DR Abernethy","year":"1985","unstructured":"Abernethy DR, Todd EL, Schwartz JB (1985) Caffeine disposition in obesity. Br J Clin Pharmacol 20(1):61\u201366","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"3_CR4_3","first-page":"378","volume":"7","author":"A Aldridge","year":"1979","unstructured":"Aldridge A, Neims AH (1979) The effects of phenobarbital and beta-naphthoflavone on the elimination kinetics and metabolite pattern of caffeine in the beagle dog. Drug Metab Dispos 7(6):378\u2013382","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"3_CR5_3","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/0006-2952(80)90102-1","volume":"29","author":"A Aldridge","year":"1980","unstructured":"Aldridge A, Neims AH (1980) Relationship between the clearance of caffeine and its 7-N-demethylation in developing beagle puppies. Biochem Pharmacol 29(3):1909\u20131914","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"3_CR6_3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/009127009903900308","volume":"39","author":"J Amchin","year":"1999","unstructured":"Amchin J, Zarycranski W, Taylor KP, Albano D, Klockowski PM (1999) Effect of venlafaxine on CYP1A2-dependent pharmacokinetics and metabolism of caffeine. J Clin Pharmacol 39(3):252\u2013259","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"3_CR7_3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000195907","volume":"58","author":"P Amodio","year":"1991","unstructured":"Amodio P, Lauro S, Rondana M, Crema G, Merkel C, Gatta A, Ruol A (1991) Theophylline pharmacokinetics and liver function indexes in chronic liver disease. Respiration 58(2):106\u2013111","journal-title":"Respiration"},{"key":"3_CR8_3","unstructured":"Anonymous (1991) International Agency for Research on Cancer (IARC) monographs on the evaluation of carcinogenic risks to humans, WHO, vol 51. Coffee, tea, mat\u00e9, methylxanthines and methylglyoxal. WHO, Geneva, p 513"},{"issue":"4424","key":"3_CR9_3","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1126\/science.515734","volume":"206","author":"JV Aranda","year":"1979","unstructured":"Aranda JV, Louridas AT, Vitullo BB, Thom P, Aldridge A, Haber R (1979) Metabolism of theophylline to caffeine in human fetal liver. Science 206(4424):1319\u20131321","journal-title":"Science"},{"issue":"2","key":"3_CR10_3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.2042-7158.1988.tb05190.x","volume":"40","author":"K Arimori","year":"1988","unstructured":"Arimori K, Nakano M (1988) Dose-dependency in the exsorption of theophylline and the intestinal dialysis of theophylline by oral activated charcoal in rats. J Pharm Pharmacol 40(2):101\u2013105","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"3_CR11_3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0006-2944(76)90010-7","volume":"16","author":"MJ Arnaud","year":"1976","unstructured":"Arnaud MJ (1976) Identification, kinetic and quantitative study of [2-14C] and [1-Me-14C] caffeine metabolites in rat\u2019s urine by chromatographic separations. Biochem Med 16(1):67\u201376","journal-title":"Biochem Med"},{"issue":"5","key":"3_CR12_3","first-page":"196","volume":"38","author":"MJ Arnaud","year":"1980","unstructured":"Arnaud MJ (1980) Metabolism of labeled paraxanthine in the rat: comparison of rat and human metabolic pathway. Nutr Rev 38(5):196\u2013200","journal-title":"Nutr Rev"},{"key":"3_CR13_3","unstructured":"Arnaud MJ (1983) The effect of dietary factors on the bioavailability of methylxanthines. Proceedings of the toxicology forum, Aspen, Colorado, pp 234\u2013243"},{"key":"3_CR14_3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-642-69823-1_1","volume-title":"caffeine","author":"MJ Arnaud","year":"1984","unstructured":"Arnaud MJ (1984) Products of metabolism of caffeine. In: Dews PB (ed) caffeine. Springer, Berlin, pp 3\u201338"},{"issue":"4","key":"3_CR15_3","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0090-9556(25)08236-4","volume":"13","author":"MJ Arnaud","year":"1985","unstructured":"Arnaud MJ (1985) Comparative metabolic disposition of [1-Me14C] caffeine in rats, mice, and Chinese hamsters. Drug Metab Dispos 13(4):471\u2013478","journal-title":"Drug Metab Dispos"},{"key":"3_CR16_3","first-page":"273","volume":"31","author":"MJ Arnaud","year":"1987","unstructured":"Arnaud MJ (1987) The pharmacology of caffeine. Prog Drug Res 31:273\u2013313","journal-title":"Prog Drug Res"},{"key":"3_CR17_3","unstructured":"Arnaud MJ (1988) The metabolism of coffee constituents in coffee, vol 3. In: Clarke RJ, Macrae R (eds) Physiology. Elsevier, London, pp 33\u201355"},{"key":"3_CR18_3","unstructured":"Arnaud MJ (1993a) Metabolism of caffeine and other components of coffee. In: Garattini S (ed) Caffeine coffee and health. Raven, New York, pp 43\u201395"},{"key":"3_CR19_3","first-page":"566","volume-title":"Encyclopaedia of food science, food technology and nutrition","author":"MJ Arnaud","year":"1993","unstructured":"Arnaud MJ (1993b) Caffeine, vol 1. In: Macrae R, Robinson RK, Sadler MJ (eds) Encyclopaedia of food science, food technology and nutrition. Academic, London, pp 566\u2013571"},{"key":"3_CR20_3","first-page":"153","volume-title":"Nicotine, caffeine and social drink, behaviour and brain function","author":"MJ Arnaud","year":"1998","unstructured":"Arnaud MJ (1998) Pharmacokinetics and metabolism of caffeine. In: Snel J, Lorist MM (eds) Nicotine, caffeine and social drink, behaviour and brain function. Harwood, Amsterdam, pp 153\u2013165"},{"issue":"3","key":"3_CR21_3","first-page":"407","volume":"52","author":"MJ Arnaud","year":"1986","unstructured":"Arnaud MJ, Ben Zvi Z, Yaari A, Gorodischer R (1986a) 1,3,8-Trimethylallantoin: a major caffeine metabolite formed by rat liver. Res Commun Chem Pathol Pharmacol 52(3):407\u2013410","journal-title":"Res Commun Chem Pathol Pharmacol"},{"issue":"6","key":"3_CR22_3","first-page":"665","volume":"37","author":"MJ Arnaud","year":"1981","unstructured":"Arnaud MJ, Bracco I (1981) Distribution and metabolism of theophylline in the pregnant rat: presence of a blood brain barrier. Experientia 37(6):665","journal-title":"Experientia"},{"key":"3_CR23_3","first-page":"645","volume-title":"Synthesis and applications of isotopically labelled compounds","author":"MJ Arnaud","year":"1989","unstructured":"Arnaud MJ, Bracco I, Getaz F (1989) Synthesis of ring labelled caffeine for the study of metabolic and pharmacokinetics mouse interstrain differences in relation to pharmacologic and toxic effects. In: Baillie TA, Jones JR (eds) Synthesis and applications of isotopically labelled compounds. Elsevier, Amsterdam, pp 645\u2013648"},{"issue":"3\u20134","key":"3_CR24_3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0378-4274(83)90187-X","volume":"16","author":"MJ Arnaud","year":"1983","unstructured":"Arnaud MJ, Bracco I, Sauvageat JL, Clerc MF (1983) Placental transfer of the major caffeine metabolite in the rat using 6-amino-5[N-formylmethylamino]1, 3[Me-14C]-dimethyluracil administered orally or intravenously to the pregnant rat. Toxicol Lett 16(3\u20134):271\u2013279","journal-title":"Toxicol Lett"},{"issue":"3","key":"3_CR25_3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1203\/00006450-198203000-00001","volume":"16","author":"MJ Arnaud","year":"1982","unstructured":"Arnaud MJ, Bracco I, Welsch C (1982a) Metabolism and distribution of labeled theophylline in the pregnant rat. Impairment of theophylline metabolism by pregnancy and absence of a blood-brain barrier in the fetus. Pediatr Res 16(3):167\u2013171","journal-title":"Pediatr Res"},{"key":"3_CR26_3","unstructured":"Arnaud MJ, Enslen M (1992) The role of paraxanthine in mediating physiological effects of caffeine. In: 14th international conference in coffee science, San Francisco, 14\u201319 July 1991. Proceedings ASIC, Paris, pp 71\u201379"},{"issue":"6","key":"3_CR27_3","first-page":"752","volume":"38","author":"MJ Arnaud","year":"1982","unstructured":"Arnaud MJ, G\u00e9taz F (1982) Postnatal establishment of a blood-brain barrier for theobromine in the rat. Experientia 38(6):752","journal-title":"Experientia"},{"issue":"6","key":"3_CR28_3","first-page":"678","volume":"39","author":"MJ Arnaud","year":"1983","unstructured":"Arnaud MJ, G\u00e9taz F (1983) Theobromine distribution in the pregnant rat and the fetus and the impairment of its metabolism due to pregnancy. Experientia 39(6):678","journal-title":"Experientia"},{"issue":"6","key":"3_CR29_3","first-page":"696","volume":"42","author":"MJ Arnaud","year":"1986","unstructured":"Arnaud MJ, Richli U, Philippossian G (1986b) Isolation and identification of paraxanthine glucuronide as the major caffeine metabolite in mice. Experientia 42(6):696","journal-title":"Experientia"},{"issue":"11\u201312","key":"3_CR30_3","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/bms.1200071113","volume":"7","author":"MJ Arnaud","year":"1980","unstructured":"Arnaud MJ, Thelin-Doerner A, Ravussin E, Acheson KJ (1980) Study of the demethylation of [1,3,7-Me-13C] caffeine in man using respiratory exchange measurements. Biomed Mass Spectrom 7(11\u201312):521\u2013524","journal-title":"Biomed Mass Spectrom"},{"issue":"3","key":"3_CR31_3","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1021\/jf60223a039","volume":"27","author":"MJ Arnaud","year":"1979","unstructured":"Arnaud MJ, Welsch C (1979a) Metabolic pathway of theobromine in the rat and identification of two new metabolites in human urine. J Agric Food Chem 27(3):524\u2013527","journal-title":"J Agric Food Chem"},{"issue":"7","key":"3_CR32_3","first-page":"946","volume":"35","author":"MJ Arnaud","year":"1979","unstructured":"Arnaud MJ, Welsch C (1979b) Metabolism of [1-Me-14C] paraxanthine in the rat: identification of a new metabolite. Experientia 35(7):946","journal-title":"Experientia"},{"key":"3_CR33_3","unstructured":"Arnaud MJ, Welsch C (1980a) Caffeine metabolism in human subjects. In: Proceedings of the ninth international colloquium on science and technology of coffee. Association Scientifique Internationale du Cafe, London, pp 385\u2013395"},{"issue":"6","key":"3_CR34_3","first-page":"704","volume":"36","author":"MJ Arnaud","year":"1980","unstructured":"Arnaud MJ, Welsch C (1980b) Quantitative analysis of theophylline metabolites by HPLC, after oral or i.v. administration. Experientia 36(6):704","journal-title":"Experientia"},{"key":"3_CR35_3","doi-asserted-by":"crossref","unstructured":"Arnaud MJ, Welsch C (1982) Theophylline and caffeine metabolism in man. In: Woodcock BG, Staib AH, Rietbrock N (eds) Methods in clinical pharmacology, 3: theophylline and other methylxanthines. Vieweg, Brunswick, pp 135\u2013148","DOI":"10.1007\/978-3-663-05268-5_18"},{"key":"3_CR36_3","first-page":"443","volume-title":"Microsomes drug oxidation and drug toxicity","author":"MJ Arnaud","year":"1982","unstructured":"Arnaud MJ, Wietholtz H, Voegelin M, Bircher J, Preisig R (1982b) Assessment of the cytochrome P-448 dependent liver enzyme system by a caffeine breath test. In: Sato R (ed) Microsomes drug oxidation and drug toxicity. Wiley, New York, pp 443\u2013444"},{"issue":"4","key":"3_CR37_3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1055\/s-2005-864099","volume":"71","author":"G Arold","year":"2005","unstructured":"Arold G, Donath F, Maurer A, Diefenbach K, Bauer S, Henneicke-von Zepelin HH, Friede M, Roots I (2005) No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John\u2019s wort extract. Planta Med 71(4):331\u2013337","journal-title":"Planta Med"},{"issue":"4","key":"3_CR38_3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1365-2125.1995.tb04562.x","volume":"40","author":"O Azcona","year":"1995","unstructured":"Azcona O, Barbanoj MJ, Torrent J, Jan\u00e9 F (1995) Evaluation of the central effects of alcohol and caffeine interaction. Br J Clin Pharmacol 40(4):393\u2013400","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"3_CR39_3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1365-2125.2006.02653.x","volume":"62","author":"JT Backman","year":"2006","unstructured":"Backman JT, Karjalainen MJ, Neuvonen M, Laitila J, Neuvonen PJ (2006) Rofecoxib is a potent inhibitor of cytochrome P450 1A2: studies with tizanidine and caffeine in healthy subjects. Br J Clin Pharmacol 62(3):345\u2013357","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"3_CR40_3","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00228-005-0037-3","volume":"61","author":"TE Bapiro","year":"2005","unstructured":"Bapiro TE, Sayi J, Hasler JA, Jande M, Rimoy G, Masselle A, Masimirembwa CM (2005) Artemisinin and thiabendazole are potent inhibitors of cytochrome P450 1A2 (CYP1A2) activity in humans. Eur J Clin Pharmacol 61(10):755\u2013761","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"3_CR41_3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/BF03190979","volume":"22","author":"C Bayar","year":"1997","unstructured":"Bayar C, Ozer I (1997) A study on the route of 1-methylurate formation in theophylline metabolism. Eur J Drug Metab Pharmacokinet 22(4):415\u2013419","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"7","key":"3_CR42_3","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.crvi.2006.01.006","volume":"329","author":"F Bchir","year":"2006","unstructured":"Bchir F, Dogui M, Ben Fradj R, Arnaud MJ, Saguem S (2006) Differences in pharmacokinetic and electroencephalographic responses to caffeine in sleep-sensitive and non-sensitive subjects. C R Biol 329(7):512\u2013519","journal-title":"C R Biol"},{"issue":"1","key":"3_CR43_3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0022-3565(25)21134-X","volume":"233","author":"CA Beach","year":"1985","unstructured":"Beach CA, Mays DC, Sterman BM, Gerber N (1985) Metabolism, distribution, seminal excretion and pharmacokinetics of caffeine in the rabbit. J Pharmacol Exp Ther 233(1):18\u201323","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"3_CR44_3","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1056\/NEJM198403223101202","volume":"310","author":"AB Becker","year":"1984","unstructured":"Becker AB, Simons KJ, Gillespie CA, Simons FE (1984) The bronchodilator effects and pharmacokinetics of caffeine in asthma. N Engl J Med 310(12):743\u2013746","journal-title":"N Engl J Med"},{"issue":"2","key":"3_CR45_3","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/bmc.736","volume":"21","author":"E Begas","year":"2007","unstructured":"Begas E, Kouvaras E, Tsakalof A, Papakosta S, Asprodini EK (2007) In vivo evaluation of CYP1A2, CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios. Biomed Chromatogr 21(2):190\u2013200","journal-title":"Biomed Chromatogr"},{"issue":"6","key":"3_CR46_3","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/0009-9236(95)90025-X","volume":"58","author":"NL Benowitz","year":"1995","unstructured":"Benowitz NL, Jacob P 3rd, Mayan H, Denaro C (1995) Sympathomimetic effects of paraxanthine and caffeine in humans. Clin Pharmacol Ther 58(6):684\u2013691","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"3_CR47_3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/BF00647281","volume":"146","author":"D Berdel","year":"1987","unstructured":"Berdel D, S\u00fcverkr\u00fcp R, Heimann G, von Berg A, Liappis N, St\u00fchmer A (1987) Total theophylline clearance in childhood: the influence of age-dependent changes in metabolism and elimination. Eur J Pediatr 146(1):41\u201343","journal-title":"Eur J Pediatr"},{"issue":"3","key":"3_CR48_3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0090-9556(25)08493-4","volume":"18","author":"T Bienvenu","year":"1990","unstructured":"Bienvenu T, Pons G, Rey E, Richard MO, d'Athis P, Arnaud MJ, Olive G (1990) Effect of growth hormone on caffeine metabolism in hypophysectomized rats. Drug Metab Dispos 18(3):327\u2013330","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"3_CR49_3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1365-2125.1983.tb01475.x","volume":"15","author":"DJ Birkett","year":"1983","unstructured":"Birkett DJ, Miners JO, Attwood J (1983) Secondary metabolism of theophylline biotransformation products in man-route of formation of 1-methyluric acid. Br J Clin Pharmacol 15(1):117\u2013119","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"3_CR50_3","first-page":"725","volume":"13","author":"DJ Birkett","year":"1985","unstructured":"Birkett DJ, Dahlqvist R, Miners JO, Lelo A, Billing B (1985) Comparison of theophylline and theobromine metabolism in man. Drug Metab Dispos 13(6):725\u2013728","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"3_CR51_3","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1365-2125.1991.tb05553.x","volume":"31","author":"DJ Birkett","year":"1991","unstructured":"Birkett DJ, Miners JO (1991) Caffeine renal clearance and urine caffeine concentrations during steady state dosing Implications for monitoring caffeine intake during sport events. Br J Clin Pharmacol 31(4):405\u2013408","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"3_CR52_3","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1203\/01.pdr.0000245909.74166.00","volume":"60","author":"MJ Blake","year":"2006","unstructured":"Blake MJ, Abdel-Rahman SM, Pearce RE, Leeder JS, Kearns GL (2006) Effect of diet on the development of drug metabolism by cytochrome P-450 enzymes in healthy infants. Pediatr Res 60(6):717\u2013723","journal-title":"Pediatr Res"},{"issue":"1","key":"3_CR53_3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/BF00613933","volume":"24","author":"J Blanchard","year":"1983","unstructured":"Blanchard J, Sawers SJA (1983a) The absolute bioavailability of caffeine in man. Eur J Clin Pharmacol 24(1):93\u201398","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"3_CR54_3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/BF01061844","volume":"11","author":"J Blanchard","year":"1983","unstructured":"Blanchard J, Sawers SJA (1983b) Comparative pharmacokinetics of caffeine in young and elderly men. J Pharmacokinet Biopharm 11(2):109\u2013126","journal-title":"J Pharmacokinet Biopharm"},{"issue":"4","key":"3_CR55_3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/j.1552-4604.1983.tb02716.x","volume":"23","author":"J Blanchard","year":"1983","unstructured":"Blanchard J, Sawers SJ (1983c) Relationship between urine flow rate and renal clearance of caffeine in man. J Clin Pharmacol 23(4):134\u2013138","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"3_CR56_3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1365-2125.1985.tb02635.x","volume":"19","author":"J Blanchard","year":"1985","unstructured":"Blanchard J, Sawers SJA, Jonkman JHG, Tang-Liu D-S (1985) Comparison of the urinary metabolite profile of caffeine in young and elderly males. Br J Clin Pharmacol 19(2):225\u2013232","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"3_CR57_3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/00007691-199202000-00008","volume":"14","author":"J Blanchard","year":"1992","unstructured":"Blanchard J, Harvey S, Morgan WJ (1992) Relationship between serum and saliva theophylline levels in patients with cystic fibrosis. Ther Drug Monit 14(1):48\u201354","journal-title":"Ther Drug Monit"},{"issue":"2","key":"3_CR58_3","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0022-3565(25)24773-5","volume":"257","author":"M Bologa","year":"1991","unstructured":"Bologa M, Tang B, Klein J, Tesoro A, Koren G (1991) Pregnancy-induced changes in drug metabolism in epileptic women. J Pharmacol Exp Ther 257(2):735\u2013740","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"3_CR59_3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/clpt.1982.132","volume":"32","author":"M Bonati","year":"1982","unstructured":"Bonati M, Latini R, Galletti F, Young JF, Tognoni G, Garattini S (1982) Caffeine disposition after oral doses. Clin Pharmacol Ther 32(1):98\u2013106","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"3_CR60_3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0300-483X(84)90143-4","volume":"30","author":"M Bonati","year":"1984","unstructured":"Bonati M, Latini R, Sadurska B, Riva E, Galletti F, Borzelleca JF, Tarka SM, Arnaud MJ, Garattini S (1984) Kinetics and metabolism of theobromine in male rats. Toxicology 30(4):327\u2013341","journal-title":"Toxicology"},{"issue":"2","key":"3_CR61_3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0090-9556(25)08150-4","volume":"13","author":"A Bortolotti","year":"1985","unstructured":"Bortolotti A, Jiritano L, Bonati M (1985) Pharmacokinetics of paraxanthine, one of the primary metabolites of caffeine, in the rat. Drug Metab Dispos 13(2):227\u2013231","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"3_CR62_3","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/S0022-3476(79)80246-2","volume":"94","author":"C Bory","year":"1979","unstructured":"Bory C, Baltassat P, Porthault M, Bethenod M, Frederich A, Aranda JV (1979) Metabolism of theophylline to caffeine in premature newborn infants. J Pediatr 94(6):988\u2013993","journal-title":"J Pediatr"},{"issue":"8120","key":"3_CR63_3","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/S0140-6736(79)91354-0","volume":"14","author":"MJ Boutroy","year":"1979","unstructured":"Boutroy MJ, Vert P, Monin P, Royer RJ, Royer-Morrot MJ (1979) Methylation of theophylline to caffeine in premature infants. Lancet 14(8120):830","journal-title":"Lancet"},{"issue":"4 Pt 1","key":"3_CR64_3","first-page":"E671","volume":"269","author":"D Bracco","year":"1995","unstructured":"Bracco D, Ferrarra J-M, Arnaud MJ, Jequier E, Schutz Y (1995) Effects of caffeine on energy metabolism, heart rate, and methylxanthine metabolism in lean and obese women. Am J Physiol 269(4 Pt 1):E671\u2013E678","journal-title":"Am J Physiol"},{"issue":"5","key":"3_CR65_3","first-page":"245","volume":"26","author":"D Brachtel","year":"1988","unstructured":"Brachtel D, Richter E (1988) Effect of altered gastric emptying on caffeine absorption. Z Gastroenterol 26(5):245\u2013251","journal-title":"Z Gastroenterol"},{"issue":"2","key":"3_CR66_3","first-page":"269","volume":"53","author":"Y Brandstetter","year":"1986","unstructured":"Brandstetter Y, Kaplanski J, van Creveld C, Ben-Zvi Z (1986) Theophylline pharmacokinetics in pregnant and lactating rats. Res Commun Chem Pathol Pharmacol 53(2):269\u2013272","journal-title":"Res Commun Chem Pathol Pharmacol"},{"issue":"1","key":"3_CR67_3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/BF00561675","volume":"17","author":"JL Brazier","year":"1980","unstructured":"Brazier JL, Descotes J, Lery N, Ollagnier M, Evreux JC (1980a) Inhibition by idrocilamide of the disposition of caffeine. Eur J Clin Pharmacol 17(1):37\u201343","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"3_CR68_3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/bms.1200070503","volume":"7","author":"JL Brazier","year":"1980","unstructured":"Brazier JL, Ribon B, Desage M, Salle B, Salle B (1980b) Study of theophylline metabolism in premature human newborns using stable isotope labelling. Biomed Mass Spectrom 7(5):189\u2013192","journal-title":"Biomed Mass Spectrom"},{"issue":"6","key":"3_CR69_3","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/0006-2952(93)90272-X","volume":"45","author":"K Br\u00f8sen","year":"1993","unstructured":"Br\u00f8sen K, Skjelbo E, Rasmussen BB, Poulsen HE, Loft S (1993) Fluvoxamine is a potent inhibitor of cytochrome P4501A2. Biochem Pharmacol 45(6):1211\u20131214","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"3_CR70_3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1211\/0022357056631","volume":"57","author":"J Brouwers","year":"2005","unstructured":"Brouwers J, Ingels F, Tack J, Augustijns P (2005) Determination of intraluminal theophylline concentrations after oral intake of an immediate- and a slow-release dosage form. J Pharm Pharmacol 57(8):987\u2013996","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"3_CR71_3","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/0091-3057(89)90559-5","volume":"34","author":"CR Brown","year":"1989","unstructured":"Brown CR, Benowitz NL (1989) Caffeine and cigarette smoking: behavioral, cardiovascular, and metabolic interactions. Pharmacol Biochem Behav 34(3):565\u2013570","journal-title":"Pharmacol Biochem Behav"},{"issue":"5","key":"3_CR72_3","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/clpt.1988.63","volume":"43","author":"CR Brown","year":"1988","unstructured":"Brown CR, Jacob P 3rd, Wilson M, Benowitz NL (1988) Changes in rate and pattern of caffeine metabolism after cigarette abstinence. Clin Pharmacol Ther 43(5):488\u2013491","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"3_CR73_3","first-page":"181","volume":"35","author":"B Bruguerolle","year":"1987","unstructured":"Bruguerolle B (1987) [Changes in the pharmacokinetics of theophylline during estrus in rats]. Pathol Biol 35(2):181\u2013183","journal-title":"Pathol Biol"},{"issue":"3","key":"3_CR74_3","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/00008571-199206000-00003","volume":"2","author":"MA Butler","year":"1992","unstructured":"Butler MA, Lang NP, Young JF, Caporaso NE, Vineis P, Hayes RB, Teitel CH, Massengill JP, Lawsen MF, Kadlubar FF (1992) Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics 2(3):116\u2013127","journal-title":"Pharmacogenetics"},{"issue":"4","key":"3_CR75_3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0090-9556(25)07906-1","volume":"10","author":"MM Callahan","year":"1982","unstructured":"Callahan MM, Robertson RS, Arnaud MJ, Branfman AR, McComish MF, Yesair DW (1982) Human metabolism of [1-methyl-14C]- and [2-14C]caffeine after oral administration. Drug Metab Dispos 10(4):417\u2013423","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"3_CR76_3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0090-9556(25)06689-9","volume":"15","author":"ME Campbell","year":"1987","unstructured":"Campbell ME, Grant DM, Inaba T, Kalow W (1987a) Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes. Drug Metab Dispos 15(2):237\u2013249","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"3_CR77_3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/clpt.1987.126","volume":"42","author":"ME Campbell","year":"1987","unstructured":"Campbell ME, Spielberg SP, Kalow W (1987b) A urinary metabolic ratio that reflects systemic caffeine clearance. Clin Pharmacol Ther 42(2):157\u2013165","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"3_CR78_3","first-page":"234","volume":"19","author":"Y Caraco","year":"1995","unstructured":"Caraco Y, Zylber-Katz E, Berry EM, Levy M (1995) Caffeine pharmacokinetics in obesity and following significant weight reduction. Int J Obes 19(4):234\u2013239","journal-title":"Int J Obes"},{"issue":"4","key":"3_CR79_3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/00007691-200008000-00008","volume":"22","author":"JA Carrillo","year":"2000","unstructured":"Carrillo JA, Christensen M, Ramos SI, Alm C, Dahl ML, Benitez J, Bertilsson L (2000) Evaluation of caffeine as an in vivo probe for CYP1A2 using measurements in plasma, saliva, and urine. Ther Drug Monit 22(4):409\u2013417","journal-title":"Ther Drug Monit"},{"issue":"7","key":"3_CR80_3","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1080\/00498250902951763","volume":"39","author":"Y Chen","year":"2009","unstructured":"Chen Y, Tu JH, He YJ, Zhang W, Wang G, Tan ZR, Zhou G, Fan L, Zhou HH (2009a) Effect of sodium tanshinone II A sulfonate on the activity of CYP1A2 in healthy volunteers. Xenobiotica 39(7):508\u2013513","journal-title":"Xenobiotica"},{"issue":"8","key":"3_CR81_3","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/j.1440-1681.2009.05158.x","volume":"36","author":"Y Chen","year":"2009","unstructured":"Chen Y, Xiao P, Ou-Yang DS, Fan L, Guo D, Wang YN, Han Y, Tu JH, Zhou G, Huang YF, Zhou HH (2009b) Simultaneous action of the flavonoid quercetin on cytochrome P450 (CYP) 1A2, CYP2A6. N-Acetyltransferase and xanthine oxidase activity in healthy volunteers. Clin Exp Pharmacol Physiol 36(8):828\u2013833","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"4","key":"3_CR82_3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/clpt.1990.66","volume":"47","author":"WS Cheng","year":"1990","unstructured":"Cheng WS, Murphy TL, Smith MT, Cooksley WG, Halliday JW, Powell LW (1990) Dose-dependent pharmacokinetics of caffeine in humans: relevance as a test of quantitative liver function. Clin Pharmacol Ther 47(4):516\u2013524","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"3_CR83_3","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0009-9236(03)00050-X","volume":"73","author":"M Christensen","year":"2003","unstructured":"Christensen M, Andersson K, Dal\u00e9n P, Mirghani RA, Muirhead GJ, Nordmark A, Tybring G, Wahlberg A, Ya\u015far U, Bertilsson L (2003) The Karolinska cocktail for phenotyping of five human cytochrome P450 enzymes. Clin Pharmacol Ther 73(6):517\u2013528","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"3_CR84_3","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1067\/mcp.2000.104617","volume":"67","author":"WG Chung","year":"2000","unstructured":"Chung WG, Kang JH, Park CS, Cho MH, Cha YN (2000) Effect of age and smoking on in vivo CYP1A2, flavin-containing monooxygenase, and xanthine oxidase activities in Koreans: determination by caffeine metabolism. Clin Pharmacol Ther 67(3):258\u2013266","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"3_CR85_3","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0016-5085(19)33396-7","volume":"61","author":"TE Chvasta","year":"1971","unstructured":"Chvasta TE, Cooke AR (1971) Emptying and absorption of caffeine from the human stomach. Gastroenterology 61(6):838\u2013843","journal-title":"Gastroenterology"},{"issue":"3","key":"3_CR86_3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/BF00315209","volume":"40","author":"K Collomp","year":"1991","unstructured":"Collomp K, Anselme F, Audran M, Gay JP, Chanal JL, Prefaut C (1991) Effects of moderate exercise on the pharmacokinetics of caffeine. Eur J Clin Pharmacol 40(3):279\u2013282","journal-title":"Eur J Clin Pharmacol"},{"key":"3_CR87_3","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/1523-1747.ep12461011","volume":"96","author":"DP Conner","year":"1991","unstructured":"Conner DP, Millora E, Zamani K, Nix D, Almirez RG, Rhyne-Kirsch P, Peck CC (1991) Transcutaneous chemical collection of caffeine in normal subjects: relationship to area under the plasma concentration-time curve and sweat production. J Invest Dermatol 96:186\u2013190","journal-title":"J Invest Dermatol"},{"issue":"4","key":"3_CR88_3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/0736-4679(93)90244-2","volume":"11","author":"DS Cooling","year":"1993","unstructured":"Cooling DS (1993) Theophylline toxicity. J Emerg Med 11(4):415\u2013425","journal-title":"J Emerg Med"},{"issue":"1","key":"3_CR89_3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0021-9258(18)70714-X","volume":"228","author":"HH Cornish","year":"1957","unstructured":"Cornish HH, Christman AA (1957) A study of the metabolism of theobromine, theophylline, and caffeine in man. J Biol Chem 228(1):315\u2013323","journal-title":"J Biol Chem"},{"issue":"2","key":"3_CR90_3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0022-3565(25)22660-X","volume":"245","author":"JJ Crowley","year":"1988","unstructured":"Crowley JJ, Cusack BJ, Jue SG, Koup JR, Park BK, Vestal RE (1988) Aging and drug interactions. II. Effect of phenytoin and smoking on the oxidation of theophylline and cortisol in healthy men. J Pharmacol Exp Ther 245(2):513\u2013523","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"3_CR91_3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/sj.clpt.6100211","volume":"82","author":"RM Cysneiros","year":"2007","unstructured":"Cysneiros RM, Farkas D, Harmatz JS, von Moltke LL, Greenblatt DJ (2007) Pharmacokinetic and pharmacodynamic interactions between zolpidem and caffeine. Clin Pharmacol Ther 82(1):54\u201362","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"3_CR92_3","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0090-9556(25)08406-5","volume":"24","author":"TJ Danielson","year":"1996","unstructured":"Danielson TJ, Golsteyn LR (1996) Systemic clearance and demethylation of caffeine in sheep and cattle. Drug Metab Dispos 24(10):1058\u20131061","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"3_CR93_3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2165\/00003088-200847010-00006","volume":"47","author":"M Darwish","year":"2008","unstructured":"Darwish M, Kirby M, Robertson P Jr, Hellriegel ET (2008) Interaction profile of armodafinil with medications metabolized by P enzymes 1A2, 3A4 and 2C19 in healthy subjects. Clin Pharmacokinet 47(1):61\u201374","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"3_CR94_3","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2460\/ajvr.1995.56.05.619","volume":"56","author":"FJ DeGraves","year":"1995","unstructured":"DeGraves FJ, Ruffin DC, Duran SH, Spano JS, Whatley EM, Schumacher J, Riddell MG (1995) Pharmacokinetics of caffeine in lactating dairy cows. Am J Vet Res 56(5):619\u2013622","journal-title":"Am J Vet Res"},{"issue":"7","key":"3_CR95_3","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/jat\/22.7.596","volume":"22","author":"T Delahunty","year":"1998","unstructured":"Delahunty T, Schoendorfer D (1998) Caffeine demethylation monitoring using a transdermal sweat patch. J Anal Toxicol 22(7):596\u2013600","journal-title":"J Anal Toxicol"},{"issue":"3","key":"3_CR96_3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/clpt.1990.150","volume":"48","author":"CP Denaro","year":"1990","unstructured":"Denaro CP, Brown CR, Wilson M, Jacob P, Benowitz NL (1990) Dose-dependency of caffeine metabolism with repeated dosing. Clin Pharmacol Ther 48(3):277\u2013285","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"3_CR97_3","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1158\/1055-9965.EPI-08-0424","volume":"17","author":"KS Derby","year":"2008","unstructured":"Derby KS, Cuthrell K, Caberto C, Carmella SG, Franke AA, Hecht SS, Murphy SE, Le Marchand L (2008) Nicotine metabolism in three ethnic\/racial groups with different risks of lung cancer. Cancer Epidemiol Biomarkers Prev 17(12):3526\u20133535","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"3_CR98_3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/01.fpc.0000167326.00411.50","volume":"15","author":"S Derkenne","year":"2005","unstructured":"Derkenne S, Curran CP, Shertzer HG, Dalton TP, Dragin N, Nebert DW (2005) Theophylline pharmacokinetics: comparison of Cyp1a1(-\/-) and Cyp1a2(-\/-) knockout mice, humanized hCYP1A1_1A2 knock-in mice lacking either the mouse Cyp1a1 or Cyp1a2 gene, and Cyp1(+\/+) wild-type mice. Pharmacogenet Genomics 15(7):503\u2013511","journal-title":"Pharmacogenet Genomics"},{"issue":"3","key":"3_CR99_3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/BF01308138","volume":"25","author":"DPV Patwardhan","year":"1980","unstructured":"Desmond PV, Patwardhan RV, Johnson RF, Schenker S (1980) Impaired elimination of caffeine in cirrhosis. Dig Dis Sci 25(3):193\u2013197","journal-title":"Dig Dis Sci"},{"issue":"4","key":"3_CR100_3","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/0002-9378(93)90353-K","volume":"168","author":"LD Devoe","year":"1993","unstructured":"Devoe LD, Murray C, Youssif A, Arnaud M (1993) Maternal caffeine consumption and fetal behavior in normal third-trimester pregnancy. Am J Obstet Gynecol 168(4):1105\u20131111 (discussion 1111\u20131112)","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"3_CR101_3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00228-007-0438-6","volume":"64","author":"N Djordjevic","year":"2008","unstructured":"Djordjevic N, Ghotbi R, Bertilsson L, Jankovic S, Aklillu E (2008) Induction of CYP1A2 by heavy coffee consumption in Serbs and Swedes. Eur J Clin Pharmacol 64(4):381\u2013385","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"3_CR102_3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/BF01062339","volume":"15","author":"SH Dorrbecker","year":"1987","unstructured":"Dorrbecker SH, Ferraina RA, Dorrbecker BR, Kramer PA (1987) Caffeine and paraxanthine pharmacokinetics in the rabbit: concentration and product inhibition effects. J Pharmacokinet Biopharm 15(2):117\u2013132","journal-title":"J Pharmacokinet Biopharm"},{"issue":"2","key":"3_CR103_3","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000457676","volume":"11","author":"SH Dorrbecker","year":"1988","unstructured":"Dorrbecker SH, Kramer PA, Dorrbecker BR, Raye JR (1988a) Caffeine disposition in the pregnant rabbit. II. Fetal distribution of caffeine and paraxanthine during chronic maternal caffeine administration. Dev Pharmacol Ther 11(2):118\u2013124","journal-title":"Dev Pharmacol Ther"},{"issue":"5","key":"3_CR105_3","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/clpt.1989.59","volume":"45","author":"CI Dothey","year":"1989","unstructured":"Dothey CI, Tserng KY, Kaw S, King KC (1989) Maturational changes of theophylline pharmacokinetics in preterm infants. Clin Pharmacol Ther 45(5):461\u2013468","journal-title":"Clin Pharmacol Ther"},{"issue":"4\u20135","key":"3_CR106_3","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ejps.2003.09.010","volume":"20","author":"LJ Doude van Troostwijk","year":"2003","unstructured":"Doude van Troostwijk LJ, Koopmans RP, Vermeulen HD, Guchelaar HJ (2003a) CYP1A2 activity is an important determinant of clozapine dosage in schizophrenic patients. Eur J Pharm Sci 20(4\u20135):451\u2013457","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"3_CR107_3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1046\/j.1472-8206.2003.00136.x","volume":"17","author":"LJ Doude van Troostwijk","year":"2003","unstructured":"Doude van Troostwijk LJ, Koopmans RP, Guchelaar HJ (2003b) Two novel methods for the determination of CYP1A2 activity using the paraxanthine\/caffeine ratio. Fundam Clin Pharmacol 17(3):355\u2013362","journal-title":"Fundam Clin Pharmacol"},{"issue":"2","key":"3_CR108_3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/BF01059025","volume":"17","author":"MS Driscoll","year":"1989","unstructured":"Driscoll MS, Ludden TM, Casto DT, Littlefield LC (1989) Evaluation of theophylline pharmacokinetics in a pediatric population using mixed effects models. J Pharmacokinet Biopharm 17(2):141\u2013168","journal-title":"J Pharmacokinet Biopharm"},{"issue":"3","key":"3_CR109_3","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/cpt1978233296","volume":"23","author":"DD Drouillard","year":"1978","unstructured":"Drouillard DD, Vesell ES, Dvorchik BH (1978) Studies on theobromine disposition in normal subjects. Alterations induced by dietary abstention from or exposure to methylxanthines. Clin Pharmacol Ther 23(3):296\u2013302","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"3_CR110_3","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1097\/00007691-199912000-00003","volume":"21","author":"MJ Preez du","year":"1999","unstructured":"du Preez MJ, Botha JH, McFadyen ML, Holford NH (1999) The pharmacokinetics of theophylline in premature neonates during the first few days after birth. Ther Drug Monit 21(6):598\u2013603","journal-title":"Ther Drug Monit"},{"issue":"4","key":"3_CR111_3","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1542\/peds.58.4.542","volume":"58","author":"EF Ellis","year":"1976","unstructured":"Ellis EF, Koysooko R, Levy G (1976) Pharmacokinetics of theophylline in children with asthma. Pediatrics 58(4):542\u2013547","journal-title":"Pediatrics"},{"issue":"2","key":"3_CR112_3","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.clpt.2004.04.003","volume":"76","author":"MS Faber","year":"2004","unstructured":"Faber MS, Fuhr U (2004) Time response of cytochrome P450 1A2 activity on cessation of heavy smoking. Clin Pharmacol Ther 76(2):178\u2013184","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"3_CR113_3","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/thx.36.5.382","volume":"36","author":"JA Fleetham","year":"1981","unstructured":"Fleetham JA, Bird CE, Nakatsu K, Wigle RD, Munt PW (1981) Dose-dependency of theophylline clearance and protein binding. Thorax 36(5):382\u2013386","journal-title":"Thorax"},{"issue":"3","key":"3_CR114_3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1046\/j.1365-2125.1998.00776.x","volume":"46","author":"RJ Fontana","year":"1998","unstructured":"Fontana RJ, deVries TM, Woolf TF, Knapp MJ, Brown AS, Kaminsky LS, Tang BK, Foster NL, Brown RR, Watkins PB (1998) Caffeine based measures of CYP1A2 activity correlate with oral clearance of tacrine in patients with Alzheimer\u2019s disease. Br J Clin Pharmacol 46(3):221\u2013228","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"3_CR115_3","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1128\/AAC.36.5.942","volume":"36","author":"U Fuhr","year":"1992","unstructured":"Fuhr U, Anders EM, Mahr G, S\u00f6rgel F, Staib AH (1992) Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA2 activity in vivo and in vitro. Antimicrob Agents Chemother 36(5):942\u2013948","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"3_CR116_3","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1365-2125.1993.tb04162.x","volume":"35","author":"U Fuhr","year":"1993","unstructured":"Fuhr U, Klittich K, Staib AH (1993) Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man. Br J Clin Pharmacol 35(4):431\u2013436","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"3_CR117_3","first-page":"311","volume":"33","author":"U Fuhr","year":"1995","unstructured":"Fuhr U, Maier A, Keller A, Steinijans VW, Sauter R, Staib AH (1995) Lacking effect of grapefruit juice on theophylline pharmacokinetics. Int J Clin Pharmacol Ther 33(6):311\u2013314","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"2","key":"3_CR118_3","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/sj.clpt.6100050","volume":"81","author":"U Fuhr","year":"2007","unstructured":"Fuhr U, Jetter A, Kirchheiner J (2007) Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the \u201ccocktail\u201d approach. Clin Pharmacol Ther 81(2):270\u201383","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"3_CR119_3","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/cpt1978234438","volume":"23","author":"P Gal","year":"1978","unstructured":"Gal P, Jusko WJ, Yurchak AM, Franklin BA (1978) Theophylline disposition in obesity. Clin Pharmacol Ther 23(4):438\u2013444","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"3_CR120_3","first-page":"157","volume":"2","author":"MJ Gardner","year":"1982","unstructured":"Gardner MJ, Jusko WJ (1982) Effect of age and sex on theophylline clearance in young subjects. Pediatr Pharmacol 2(2):157\u2013169","journal-title":"Pediatr Pharmacol"},{"issue":"3","key":"3_CR121_3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1365-2125.1983.tb02161.x","volume":"16","author":"MJ Gardner","year":"1983","unstructured":"Gardner MJ, Tornatore KM, Jusko WJ, Kanarkowski R (1983) Effects of tobacco smoking and oral contraceptive use on theophylline disposition. Br J Clin Pharmacol 16(3):271\u2013280","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"3_CR122_3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/BF00607577","volume":"32","author":"MJ Gardner","year":"1987","unstructured":"Gardner MJ, Schatz M, Cousins L, Zeiger R, Middleton E, Jusko WJ (1987) Longitudinal effects of pregnancy on the pharmacokinetics of theophylline. Eur J Clin Pharmacol 32(3):289\u2013295","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"3_CR123_3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1046\/j.1365-2125.1999.00890.x","volume":"47","author":"S Gates","year":"1999","unstructured":"Gates S, Miners JO (1999) Cytochrome P450 isoform selectivity in human hepatic theobromine metabolism. Br J Clin Pharmacol 47(3):299\u2013305","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"3_CR124_3","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/j.1440-1681.1986.tb02414.x","volume":"13","author":"J George","year":"1986","unstructured":"George J, Murphy T, Roberts R, Cooksley WG, Halliday JW, Powell LW (1986) Influence of alcohol and caffeine consumption on caffeine elimination. Clin Exp Pharmacol Physiol 13(10):731\u2013736","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"6","key":"3_CR125_3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00228-007-0288-2","volume":"63","author":"R Ghotbi","year":"2007","unstructured":"Ghotbi R, Christensen M, Roh HK, Ingelman-Sundberg M, Aklillu E, Bertilsson L (2007) Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans. Eur J Clin Pharmacol 63(6):537\u2013546","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"3_CR126_3","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/0272-0590(85)90105-8","volume":"5","author":"SG Gilbert","year":"1985","unstructured":"Gilbert SG, Stavric B, Klassen RD, Rice DC (1985) The fate of chronically consumed caffeine in the monkey (Macaca fascicularis). Fundam Appl Toxicol 5(3):578\u2013587","journal-title":"Fundam Appl Toxicol"},{"issue":"4","key":"3_CR127_3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/BF00613531","volume":"31","author":"R Gorodischer","year":"1986","unstructured":"Gorodischer R, Zmora E, Ben-Zvi Z, Warszawski D, Yaari A, Sofer S, Arnaud MJ (1986a) Urinary metabolites of caffeine in the premature infant. Eur J Clin Pharmacol 31(4):497\u2013499","journal-title":"Eur J Clin Pharmacol"},{"issue":"18","key":"3_CR128_3","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1016\/0006-2952(86)90389-8","volume":"35","author":"R Gorodischer","year":"1986","unstructured":"Gorodischer R, Yaari A, Margalith M, Warszawski D, Ben-Zvi Z (1986b) Changes in theophylline metabolism during postnatal development in rat liver slices. Biochem Pharmacol 35(18):3077\u20133081","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"3_CR129_3","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.clpt.2004.08.018","volume":"76","author":"MT Granfors","year":"2004","unstructured":"Granfors MT, Backman JT, Neuvonen M, Neuvonen PJ (2004) Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism. Clin Pharmacol Ther 76(6):598\u2013606","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"3_CR130_3","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.clpt.2005.06.009","volume":"78","author":"MT Granfors","year":"2005","unstructured":"Granfors MT, Backman JT, Laitila J, Neuvonen PJ (2005) Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2. Clin Pharmacol Ther 78(4):400\u2013411","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"3_CR131_3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/clpt.1983.45","volume":"33","author":"DM Grant","year":"1983","unstructured":"Grant DM, Tang BK, Kalow W (1983) Polymorphic N-acetylation of a caffeine metabolite. Clin Pharmacol Ther 33(3):355\u2013359","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"3_CR132_3","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1365-2125.1984.tb02372.x","volume":"17","author":"DM Grant","year":"1984","unstructured":"Grant DM, Tang BK, Kalow W (1984) A simple test for acetylation phenotype using caffeine. Br J Clin Pharmacol 17(4):459\u2013464","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"3_CR133_3","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/j.1365-2125.1986.tb05222.x","volume":"21","author":"DM Grant","year":"1986","unstructured":"Grant DM, Tang BK, Campbell ME, Kalow W (1986) Effect of allopurinol on caffeine disposition in man. Br J Clin Pharmacol 21(4):454\u2013458","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"3_CR134_3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.2165\/00003088-199325020-00006","volume":"25","author":"K Groen","year":"1993","unstructured":"Groen K, Horan MA, Roberts NA, Gulati RS, Miljkovic B, Jansen EJ, Paramsothy V, Breimer DD, van Bezooijen CF (1993) The relationship between phenazone (antipyrine) metabolite formation and theophylline metabolism in healthy and frail elderly women. Clin Pharmacokinet 25(2):136\u2013144","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"3_CR135_3","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.annepidem.2004.12.011","volume":"15","author":"LM Grosso","year":"2005","unstructured":"Grosso LM, Bracken MB (2005) Caffeine metabolism, genetics, and perinatal outcomes: a review of exposure assessment considerations during pregnancy. Ann Epidemiol 15(6):460\u2013466","journal-title":"Ann Epidemiol"},{"issue":"3","key":"3_CR136_3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.annepidem.2007.11.005","volume":"18","author":"LM Grosso","year":"2008","unstructured":"Grosso LM, Triche E, Benowitz NL, Bracken MB (2008) Prenatal caffeine assessment: fetal and maternal biomarkers or self-reported intake? Ann Epidemiol 18(3):172\u2013178","journal-title":"Ann Epidemiol"},{"issue":"4","key":"3_CR137_3","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/clpt.1980.188","volume":"28","author":"JJ Grygiel","year":"1980","unstructured":"Grygiel JJ, Birkett DJ (1980) Effect of age on patterns of theophylline metabolism. Clin Pharmacol Ther 28(4):456\u2013462","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"3_CR138_3","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/clpt.1981.193","volume":"30","author":"JJ Grygiel","year":"1981","unstructured":"Grygiel JJ, Birkett DJ (1981) Cigarette smoking and theophylline clearance and metabolism. Clin Pharmacol Ther 30(4):491\u2013496","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"3_CR139_3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/00008571-199204000-00004","volume":"2","author":"L Gu","year":"1992","unstructured":"Gu L, Gonzalez FJ, Kalow W, Tang BK (1992) Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1. Pharmacogenetics 2(2):73\u201377","journal-title":"Pharmacogenetics"},{"issue":"3","key":"3_CR140_3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1067\/mcp.2002.126913","volume":"72","author":"BJ Gurley","year":"2002","unstructured":"Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui Y, Ang CY (2002) Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans. Clin Pharmacol Ther 72(3):276\u2013287","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"3_CR141_3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1365-2125.1995.tb04455.x","volume":"39","author":"HR Ha","year":"1995","unstructured":"Ha HR, Chen J, Freiburghaus AU, Follath F (1995) Metabolism of theophylline by cDNA-expressed human s P. Br J Clin Pharmacol 39(3):321\u2013326","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"3_CR142_3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/BF00226333","volume":"49","author":"HR Ha","year":"1996","unstructured":"Ha HR, Chen J, Krahenbuhl S, Follath F (1996) Biotransformation of caffeine by cDNA-expressed human s P. Eur J Clin Pharmacol 49(4):309\u2013315","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"3_CR143_3","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1067\/mcp.2002.124523","volume":"71","author":"CA Haller","year":"2002","unstructured":"Haller CA, Jacob P 3rd, Benowitz NL (2002) Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use. Clin Pharmacol Ther 71(6):421\u2013432","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"3_CR144_3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2515\/therapie:2004048","volume":"59","author":"B Hamon-Vilcot","year":"2004","unstructured":"Hamon-Vilcot B, Simon T, Becquemont L, Poirier JM, Piette F, Jaillon P (2004) Effects of malnutrition on cytochrome P450 1A2 activity in elderly patients. Therapie 59(2):247\u2013251","journal-title":"Therapie"},{"issue":"2","key":"3_CR145_3","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/j.1552-4604.1992.tb03824.x","volume":"32","author":"M Hashiguchi","year":"1992","unstructured":"Hashiguchi M, Fujimura A, Ohashi K, Ebihara A (1992) Diurnal effect on caffeine clearance. J Clin Pharmacol 32(2):184\u2013187","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"3_CR146_3","first-page":"525","volume":"34","author":"L Hendeles","year":"1977","unstructured":"Hendeles L, Weinberger M, Bighley L (1977) Absolute bioavailability of oral theophylline. Am J Hosp Pharm 34(5):525\u2013527","journal-title":"Am J Hosp Pharm"},{"key":"3_CR147_3","unstructured":"Hendeles L, Massanari MJ, Weinberger M (1986) Theophylline. In: Evans WE, Schentag JJ, Jusko WJ (eds) Applied pharmacokinetics, 2nd edn. Applied Therapeutics, San Francisco, pp 1105\u20131188"},{"issue":"1","key":"3_CR148_3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/BF01736528","volume":"67","author":"A Holstege","year":"1989","unstructured":"Holstege A, Staiger M, Haag K, Gerok W (1989) Correlation of caffeine elimination and Child\u2019s classification in liver cirrhosis. Klin Wochenschr 67(1):6\u201315","journal-title":"Klin Wochenschr"},{"issue":"2","key":"3_CR149_3","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1248\/bpb.32.304","volume":"32","author":"T Igarashi","year":"2009","unstructured":"Igarashi T, Iwakawa S (2009) Effect of gender on theophylline clearance in the asthmatic acute phase in Japanese pediatric patients. Biol Pharm Bull 32(2):304\u2013307","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"3_CR150_3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1365-2885.1992.tb01030.x","volume":"15","author":"C Ingvast-Larsson","year":"1992","unstructured":"Ingvast-Larsson C, Appelgren LE, Nyman G (1992) Distribution studies of theophylline: microdialysis in rat and horse and whole body autoradiography in rat. J Vet Pharmacol Ther 15(4):386\u2013394","journal-title":"J Vet Pharmacol Ther"},{"issue":"1","key":"3_CR151_3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/BF00561019","volume":"36","author":"SH Jackson","year":"1989","unstructured":"Jackson SH, Johnston A, Woollard R, Turner P (1989) The relationship between theophylline clearance and age in adult life. Eur J Clin Pharmacol 36(1):29\u201334","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"3_CR152_3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3109\/15563658608992604","volume":"24","author":"CH Jarboe","year":"1986","unstructured":"Jarboe CH, Hurst HE, Rodgers GC, Metaxas JM (1986) Toxicokinetics of caffeine elimination in an infant. Clin Toxicol 24(5):415\u2013428","journal-title":"Clin Toxicol"},{"issue":"2","key":"3_CR153_3","first-page":"208","volume":"122","author":"TS Jennings","year":"1993","unstructured":"Jennings TS, Nafziger AN, Davidson L, Bertino JS Jr (1993) Gender differences in hepatic induction and inhibition of theophylline pharmacokinetics and metabolism. J Lab Clin Med 122(2):208\u2013216","journal-title":"J Lab Clin Med"},{"issue":"3","key":"3_CR154_3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/00008571-199606000-00003","volume":"6","author":"U Jeppesen","year":"1996","unstructured":"Jeppesen U, Loft S, Poulsen HE, Br\u00f8sen K (1996) A fluvoxamine-caffeine interaction study. Pharmacogenetics 6(3):213\u2013222","journal-title":"Pharmacogenetics"},{"issue":"4","key":"3_CR155_3","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1177\/0091270004263468","volume":"44","author":"J Jodynis-Liebert","year":"2004","unstructured":"Jodynis-Liebert J, Flieger J, Matuszewska A, Juszczyk J (2004) Serum metabolite\/caffeine ratios as a test for liver function. J Clin Pharmacol 44(4):338\u2013347","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"3_CR156_3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF00609697","volume":"28","author":"JH Jonkman","year":"1985","unstructured":"Jonkman JH, van der Boon WJ, Balant LP, Le Cotonnec JY (1985) Food reduces the rate but not the extent of the absorption of theophylline from an aqueous solution. Eur J Clin Pharmacol 28(2):225\u2013227","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"3_CR157_3","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/clpt.1991.24","volume":"49","author":"JH Jonkman","year":"1991","unstructured":"Jonkman JH, Sollie FA, Sauter R, Steinijans VW (1991) The influence of caffeine on the steady-state pharmacokinetics of theophylline. Clin Pharmacol Ther 49(3):248\u2013255","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"3_CR158_3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0773.1990.tb00763.x","volume":"66","author":"D Jung","year":"1990","unstructured":"Jung D, Nanavaty M (1990) The effects of age and dietary protein restriction on the pharmacokinetics of theophylline in the rat. Pharmacol Toxicol 66(5):361\u2013366","journal-title":"Pharmacol Toxicol"},{"issue":"2","key":"3_CR159_3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3109\/03602537908993892","volume":"9","author":"WJ Jusko","year":"1979","unstructured":"Jusko WJ (1979) Influence of cigarette smoking on drug metabolism in man. Drug Metab Rev 9(2):221\u2013236","journal-title":"Drug Metab Rev"},{"issue":"11","key":"3_CR160_3","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1002\/jps.2600681106","volume":"68","author":"WJ Jusko","year":"1979","unstructured":"Jusko WJ, Gardner MJ, Mangione A, Schentag JJ, Koup JR, Vance JW (1979) Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol. J Pharm Sci 68(11):1358\u20131366","journal-title":"J Pharm Sci"},{"key":"3_CR161_3","first-page":"107","volume":"340B","author":"FF Kadlubar","year":"1990","unstructured":"Kadlubar FF, Butler TG, MA TCH, Massengill JP, Lang NP (1990) Determination of carcinogenic arylamine N-oxidation phenotype in humans by analysis of caffeine urinary metabolites. Prog Clin Biol Res 340B:107\u2013114","journal-title":"Prog Clin Biol Res"},{"issue":"10","key":"3_CR162_3","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1177\/096032719501401004","volume":"14","author":"MA Kall","year":"1995","unstructured":"Kall MA, Clausen J (1995) Dietary effect on mixed function P4501A2 activity assayed by estimation of caffeine metabolism in man. Hum Exp Toxicol 14(10):801\u2013807","journal-title":"Hum Exp Toxicol"},{"key":"3_CR163_3","first-page":"331","volume":"214","author":"W Kalow","year":"1986","unstructured":"Kalow W (1986) Ethnic differences in reactions to drugs and xenobiotics Caffeine and other drugs. Prog Clin Biol Res 214:331\u2013341","journal-title":"Prog Clin Biol Res"},{"issue":"5 Pt 1","key":"3_CR164_3","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/clpt.1991.176","volume":"50","author":"W Kalow","year":"1991","unstructured":"Kalow W, Tang BK (1991a) Use of caffeine metabolic ratios to explore CYP1A2 and xanthine oxidase activities. Clin Pharmacol Ther 50(5 Pt 1):508\u2013519","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"3_CR165_3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/clpt.1991.8","volume":"49","author":"W Kalow","year":"1991","unstructured":"Kalow W, Tang BK (1991b) Caffeine as a metabolic probe: exploration of the enzyme-inducing effect of cigarette smoking. Clin Pharmacol Ther 49(1):44\u201348","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"3_CR166_3","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1248\/cpb.23.683","volume":"23","author":"K Kamei","year":"1975","unstructured":"Kamei K, Matsuda M, Momose A (1975) New sulfur-containing metabolites of caffeine. Chem Pharm Bull 23(3):683\u2013685","journal-title":"Chem Pharm Bull"},{"issue":"5","key":"3_CR167_3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/BF00606637","volume":"31","author":"GH Kamimori","year":"1987","unstructured":"Kamimori GH, Somani SM, Knowlton RG, Perkins RM (1987) The effects of obesity and exercise on the pharmacokinetics of caffeine in lean and obese volunteers. Eur J Clin Pharmacol 31(5):595\u2013600","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"3_CR168_3","first-page":"182","volume":"33","author":"GH Kamimori","year":"1995","unstructured":"Kamimori GH, Lugo SI, Penetar DM, Chamberlain AC, Brunhart GE, Brunhart AE, Eddington ND (1995) Dose-dependent caffeine pharmacokinetics during severe sleep deprivation in humans. Int J Clin Pharmacol Ther 33(3):182\u2013186","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"3","key":"3_CR169_3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1358\/mf.2000.22.3.796116","volume":"22","author":"H Kawai","year":"2000","unstructured":"Kawai H, Kokubun S, Matsumoto T, Kojima J, Onodera K (2000) Pharmacokinetic study of theophylline in dogs after intravenous administration with and without ethylenediamine. Methods Find Exp Clin Pharmacol 22(3):179\u2013184","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"6","key":"3_CR170_3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000457263","volume":"9","author":"GL Kearns","year":"1986","unstructured":"Kearns GL, Hill DE, Tumbelson ME (1986) Theophylline and caffeine disposition in the neonatal piglet. Dev Pharmacol Ther 9(6):389\u2013401","journal-title":"Dev Pharmacol Ther"},{"issue":"4","key":"3_CR171_3","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/clpt.1990.59","volume":"47","author":"AJ Kilbane","year":"1990","unstructured":"Kilbane AJ, Silbart LK, Manis M, Beitins IZ, Weber WW (1990) Human N-acetylation genotype determination with urinary caffeine metabolites. Clin Pharmacol Ther 47(4):470\u2013477","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"3_CR172_3","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ejps.2005.05.004","volume":"26","author":"YC Kim","year":"2005","unstructured":"Kim YC, Lee AK, Lee JH, Lee I, Lee DC, Kim SH, Kim SG, Lee MG (2005) Pharmacokinetics of theophylline in diabetes mellitus rats: induction of CYP1A2 and CYP2E1 on 1,3-dimethyluric acid formation. Eur J Pharm Sci 26(1):114\u2013123","journal-title":"Eur J Pharm Sci"},{"issue":"2 Pt 1","key":"3_CR173_3","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/0272-0590(84)90125-8","volume":"4","author":"CA Kimmel","year":"1984","unstructured":"Kimmel CA, Kimmel GL, White CG, Grafton TF, Young JF, Nelson CJ (1984) Blood flow changes and conceptal development in pregnant rats in response to caffeine. Fundam Appl Toxicol 4(2 Pt 1):240\u2013247","journal-title":"Fundam Appl Toxicol"},{"issue":"9","key":"3_CR174_3","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1124\/dmd.105.004796","volume":"33","author":"M Kimura","year":"2005","unstructured":"Kimura M, Yamazaki H, Fujieda M, Kiyotani K, Honda G, Saruwatari J, Nakagawa K, Ishizaki T, Kamataki T (2005) Cyp2a6 is a principal enzyme involved in hydroxylation of 1,7-dimethylxanthine, a main caffeine metabolite, in humans. Drug Metab Dispos 33(9):1361\u20131366","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"3_CR175_3","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S0009-9236(99)70105-0","volume":"65","author":"M Kinzig-Schippers","year":"1999","unstructured":"Kinzig-Schippers M, Fuhr U, Zaigler M, Dammeyer J, R\u00fcsing G, Labedzki A, Bulitta J, S\u00f6rgel F (1999) Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2. Clin Pharmacol Ther 65(3):262\u2013274","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"3_CR176_3","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.3109\/00498259309059448","volume":"23","author":"GO Kokwaro","year":"1993","unstructured":"Kokwaro GO, Szwandt IS, Glazier AP, Ward SA, Edwards G (1993) Metabolism of caffeine and theophylline in rats with malaria and endotoxin-induced fever. Xenobiotica 23(12):1391\u20131397","journal-title":"Xenobiotica"},{"issue":"3","key":"3_CR177_3","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/archpedi.1987.04460030060025","volume":"141","author":"GB Kolski","year":"1987","unstructured":"Kolski GB, Levy J, Anolik R (1987) The use of theophylline clearance in pediatric status asthmaticus. I. Interpatient and intrapatient theophylline clearance variability. Am J Dis Child 141(3):282\u2013287","journal-title":"Am J Dis Child"},{"issue":"4","key":"3_CR178_3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/0009-9236(95)90210-4","volume":"57","author":"MR Korrapati","year":"1995","unstructured":"Korrapati MR, Vestal RE, Loi CM (1995) Theophylline metabolism in healthy nonsmokers and in patients with insulin-dependent diabetes mellitus. Clin Pharmacol Ther 57(4):413\u2013418","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"3_CR179_3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/clpt.1982.157","volume":"32","author":"AN Kotake","year":"1982","unstructured":"Kotake AN, Schoeller DA, Lambert GH, Baker AL, Schaffer DO, Josephs H (1982) The caffeine CO2 breath test: dose response and route of N-demethylation in smokers and nonsmokers. Clin Pharmacol Ther 32(2):261\u2013269","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"3_CR180_3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/clpt.1993.160","volume":"54","author":"DM Kraus","year":"1993","unstructured":"Kraus DM, Fischer JH, Reitz SJ, Kecskes SA, Yeh TF, McCulloch KM, Tung EC, Cwik MJ (1993) Alterations in theophylline metabolism during the first year of life. Clin Pharmacol Ther 54(4):351\u2013359","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"3_CR181_3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/BF02974236","volume":"17","author":"HJ Kuh","year":"1994","unstructured":"Kuh HJ, Shim CK (1994) Nonlinear renal excretion of theophylline and its metabolites, 1-methyluric acid and 1,3-dimethyluric acid, in rats. Arch Pharm Res 17(2):124\u2013130","journal-title":"Arch Pharm Res"},{"issue":"12","key":"3_CR182_3","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/S0006-2952(02)01019-5","volume":"63","author":"A Labedzki","year":"2002","unstructured":"Labedzki A, Buters J, Jabrane W, Fuhr U (2002) Differences in caffeine and paraxanthine metabolism between human and murine CYP1A2. Biochem Pharmacol 63(12):2159\u201367","journal-title":"Biochem Pharmacol"},{"key":"3_CR183_3","first-page":"173","volume":"148","author":"MT Landi","year":"1999","unstructured":"Landi MT, Sinha R, Lang NP, Kadlubar FF (1999) Human cytochrome P4501A2. IARC Sci Publ 148:173\u2013195","journal-title":"IARC Sci Publ"},{"issue":"5","key":"3_CR184_3","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/BF02285099","volume":"43","author":"JD Lane","year":"1992","unstructured":"Lane JD, Steege JF, Rupp SL, Kuhn CM (1992) Menstrual cycle effects on caffeine elimination in the human female. Eur J Clin Pharmacol 43(5):543\u2013546","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"3_CR185_3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0378-4274(78)90024-3","volume":"2","author":"R Latini","year":"1978","unstructured":"Latini R, Bonati M, Castelli D, Garattini S (1978) Dose-dependent kinetics of caffeine in rats. Toxicol Lett 2(5):267\u2013270","journal-title":"Toxicol Lett"},{"issue":"3","key":"3_CR186_3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0378-4274(81)90080-1","volume":"7","author":"R Latini","year":"1981","unstructured":"Latini R, Bonati M, Marzi E, Garattini S (1981) Urinary excretion of an uracilic metabolite from caffeine by rat, monkey and man. Toxicol Lett 7(3):267\u2013272","journal-title":"Toxicol Lett"},{"issue":"4","key":"3_CR187_3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0300-483X(84)90144-6","volume":"30","author":"R Latini","year":"1984","unstructured":"Latini R, Bonati M, Gaspari F, Traina GL, Jiritano L, Bortolotti A, Borzelleca JF, Tarka SM, Arnaud MJ, Garattini S (1984) Kinetics and metabolism of theobromine in male and female non-pregnant and pregnant rabbits. Toxicology 30(4):343\u2013354","journal-title":"Toxicology"},{"issue":"2","key":"3_CR188_3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0091-3057(94)00306-4","volume":"50","author":"CE Lau","year":"1995","unstructured":"Lau CE, Ma F, Falk JL (1995) Oral and IP caffeine pharmacokinetics under a chronic food-limitation condition. Pharmacol Biochem Behav 50(2):245\u2013252","journal-title":"Pharmacol Biochem Behav"},{"issue":"6","key":"3_CR189_3","first-page":"449","volume":"5","author":"L Marchand Le","year":"1996","unstructured":"Le Marchand L, Sivaraman L, Franke AA, Custer LJ, Wilkens LR, Lau AF, Cooney RV (1996) Predictors of N-acetyltransferase activity: should caffeine phenotyping and NAT2 genotyping be used interchangeably in epidemiological studies? Cancer Epidemiol Biomarkers Prev 5(6):449\u2013455","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"3_CR190_3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1365-2125.1996.tb00182.x","volume":"41","author":"TC Lee","year":"1996","unstructured":"Lee TC, Charles BG, Steer PA, Flenady VJ, Grant TC (1996) Theophylline population pharmacokinetics from routine monitoring data in very premature infants with apnoea. Br J Clin Pharmacol 41(3):191\u2013200","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"3_CR191_3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1365-2125.1986.tb05246.x","volume":"22","author":"A Lelo","year":"1986","unstructured":"Lelo A, Birkett DJ, Robson RA, Miners JO (1986a) Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man. Br J Clin Pharmacol 22(2):177\u2013182","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"3_CR192_3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2125.1986.tb05247.x","volume":"22","author":"A Lelo","year":"1986","unstructured":"Lelo A, Miners JO, Robson RA, Birkett DJ (1986b) Quantitative assessment of caffeine partial clearances in man. Br J Clin Pharmacol 22(2):183\u2013186","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"3_CR194_3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0022-3565(25)23651-5","volume":"248","author":"A Lelo","year":"1989","unstructured":"Lelo A, Kjellen G, Birkett DJ, Miners JO (1989) Paraxanthine metabolism in humans: determination of metabolic partial clearances and effects of allopurinol and cimetidine. J Pharmacol Exp Ther 248(1):315\u2013319","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"3_CR195_3","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3109\/00498259009046896","volume":"20","author":"A Lelo","year":"1990","unstructured":"Lelo A, Birkett DJ, Miners JO (1990) Mechanism of formation of 6-amino-5-(N-methylformylamino)-1-methyluracil and 3,7-dimethyluric acid from theobromine in the rat in vitro: involvement of P- and a cellular thiol. Xenobiotica 20(8):823\u2013833","journal-title":"Xenobiotica"},{"issue":"5","key":"3_CR196_3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2165\/00007256-200434050-00002","volume":"34","author":"TL Lenz","year":"2004","unstructured":"Lenz TL, Lenz NJ, Faulkner MA (2004) Potential interactions between exercise and drug therapy. Sports Med 34(5):293\u2013306","journal-title":"Sports Med"},{"issue":"6","key":"3_CR197_3","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/clpt.1981.110","volume":"29","author":"LJ Lesko","year":"1981","unstructured":"Lesko LJ, Tabor KJ, Johnson BF (1981) Theophylline serum protein binding in obstructive airways disease. Clin Pharmacol Ther 29(6):776\u2013781","journal-title":"Clin Pharmacol Ther"},{"key":"3_CR198_3","first-page":"97","volume":"1","author":"M Levy","year":"1984","unstructured":"Levy M, Granit L, Zylber-Katz E (1984) Chronopharmacokinetics of caffeine in healthy volunteers. Annu Rev Chronopharmacol 1:97\u2013100","journal-title":"Annu Rev Chronopharmacol"},{"issue":"2","key":"3_CR199_3","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0022-3565(24)36457-2","volume":"280","author":"CM Loi","year":"1997","unstructured":"Loi CM, Parker BM, Cusack BJ, Vestal RE (1997) Aging and drug interactions. III. Individual and combined effects of cimetidine and cimetidine and ciprofloxacin on theophylline metabolism in healthy male and female nonsmokers. J Pharmacol Exp Ther 280(2):627\u2013637","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"3_CR200_3","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/archpedi.155.8.934","volume":"155","author":"JA Lowry","year":"2001","unstructured":"Lowry JA, Jarrett RV, Wasserman G, Pettett G, Kauffman RE (2001) Theophylline toxicokinetics in premature newborns. Arch Pediatr Adolesc Med 155(8):934\u2013939","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"1","key":"3_CR201_3","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1006\/bbrc.1998.9102","volume":"249","author":"KM Madyastha","year":"1998","unstructured":"Madyastha KM, Sridhar GR (1998) A novel pathway for the metabolism of caffeine by a mixed culture consortium. Biochem Biophys Res Commun 249(1):178\u2013181","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"3_CR202_3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1592\/phco.20.3.182.34775","volume":"20","author":"GR Matzke","year":"2000","unstructured":"Matzke GR, Frye RF, Early JJ, Straka RJ, Carson SW (2000) Evaluation of the influence of diabetes mellitus on antipyrine metabolism and CYP1A2 and CYP2D6 activity. Pharmacotherapy 20(2):182\u2013190","journal-title":"Pharmacotherapy"},{"issue":"4","key":"3_CR203_3","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1152\/japplphysiol.00762.2000","volume":"93","author":"C McLean","year":"2002","unstructured":"McLean C, Graham TE (2002) Effects of exercise and thermal stress on caffeine pharmacokinetics in men and eumenorrheic women. J Appl Physiol 93(4):1471\u20131478","journal-title":"J Appl Physiol"},{"issue":"6","key":"3_CR204_3","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.2042-7158.1988.tb06301.x","volume":"40","author":"ME McManus","year":"1988","unstructured":"McManus ME, Miners JO, Gregor D, Stupans I, Birkett DJ (1988) Theophylline metabolism by human, rabbit and rat liver microsomes and by purified forms of cytochrome P450. J Pharm Pharmacol 40(6):388\u2013391","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"3_CR205_3","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0090-9556(25)08596-4","volume":"20","author":"PJ McNamara","year":"1992","unstructured":"McNamara PJ, Burgio D, Yoo SD (1992) Pharmacokinetics of caffeine and its demethylated metabolites in lactating adult rabbits and neonatal offspring. Predictions of breast milk to serum concentration ratios. Drug Metab Dispos 20(2):302\u2013308","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"3_CR206_3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0090-9556(25)07699-8","volume":"12","author":"GE Miller","year":"1984","unstructured":"Miller GE, Radulovic LL, DeWit RH, Brabec MJ, Tarka SM, Cornish HH (1984) Comparative theobromine metabolism in five mammalian species. Drug Metab Dispos 12(2):154\u2013160","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"3_CR207_3","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0090-9556(25)07955-3","volume":"10","author":"JO Miners","year":"1982","unstructured":"Miners JO, Attwood J, Birkett DJ (1982) Theobromine metabolism in man. Drug Metab Dispos 10(6):672\u2013675","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"3_CR208_3","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0090-9556(25)08257-1","volume":"13","author":"JO Miners","year":"1985","unstructured":"Miners JO, Attwood J, Wing LM, Birkett DJ (1985) Influence of cimetidine, sulfinpyrazone, and cigarette smoking on theobromine metabolism in man. Drug Metab Dispos 13(5):598\u2013601","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"3_CR209_3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/cpt1979264513","volume":"26","author":"TJ Monks","year":"1979","unstructured":"Monks TJ, Caldwell J, Smith RL (1979) Influence of methylxanthine-containing foods on theophylline metabolism and kinetics. Clin Pharmacol Ther 26(4):513\u2013524","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"3_CR210_3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/bdd.2510020104","volume":"2","author":"TJ Monks","year":"1981","unstructured":"Monks TJ, Lawrie CA, Caldwell J (1981) The effect of increased caffeine intake on the metabolism and pharmacokinetics of theophylline in man. Biopharm Drug Dispos 2(1):31\u201337","journal-title":"Biopharm Drug Dispos"},{"issue":"1","key":"3_CR211_3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/BF01059087","volume":"17","author":"ES Moore","year":"1989","unstructured":"Moore ES, Faix RG, Banagale RC, Grasela TH (1989) The population pharmacokinetics of theophylline in neonates and young infants. J Pharmacokinet Biopharm 17(1):47\u201366","journal-title":"J Pharmacokinet Biopharm"},{"issue":"3","key":"3_CR212_3","first-page":"221","volume":"47","author":"C Morisot","year":"1990","unstructured":"Morisot C, Simoens C, Trublin F, Lhermitte M, Gremillet C, Robert MH, Lequin P (1990) Efficacit\u00e9 de la caffeine transcutan\u00e9e dans le traitement des apn\u00e9es du pr\u00e9matur\u00e9. Arch Fr Pediatr 47(3):221\u2013224","journal-title":"Arch Fr Pediatr"},{"issue":"15","key":"3_CR213_3","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1080\/01932690801934513","volume":"71","author":"T Mose","year":"2008","unstructured":"Mose T, Kjaerstad MB, Mathiesen L, Nielsen JB, Edelfors S, Knudsen LE (2008) Placental passage of benzoic acid, caffeine, and glyphosate in an ex vivo human perfusion system. J Toxicol Environ Health A 71(15):984\u2013991","journal-title":"J Toxicol Environ Health A"},{"issue":"3\u20134","key":"3_CR214_3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s002280050205","volume":"51","author":"GK Mumford","year":"1996","unstructured":"Mumford GK, Benowitz NL, Evans SM, Kaminski BJ, Preston KL, Sannerud CA, Silverman K, Griffiths RR (1996) Absorption rate of methylxanthines following capsules, cola and chocolate. Eur J Clin Pharmacol 51(3\u20134):319\u2013325","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"3_CR215_3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1440-1681.1988.tb01003.x","volume":"15","author":"TL Murphy","year":"1988","unstructured":"Murphy TL, McIvor C, Yap A, Cooksley WG, Halliday JW, Powell LW (1988) The effect of smoking on caffeine elimination: implications for its use as a semiquantitative test of liver function. Clin Exp Pharmacol Physiol 15(1):9\u201313","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"4","key":"3_CR216_3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/BF03190188","volume":"18","author":"RD Murray","year":"1993","unstructured":"Murray RD, Breech L, Ailabouni A, Zingerelli J, Nahata MC (1993) Absorption of theophylline from the small and large intestine of the neonatal piglet. Eur J Drug Metab Pharmacokinet 18(4):375\u2013379","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"7","key":"3_CR217_3","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.bcp.2008.07.024","volume":"76","author":"JE Muscat","year":"2008","unstructured":"Muscat JE, Pittman B, Kleinman W, Lazarus P, Stellman SD, Richie JP Jr (2008) Comparison of CYP1A2 and NAT2 phenotypes between black and white smokers. Biochem Pharmacol 76(7):929\u2013937","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"3_CR218_3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0168-8278(90)90044-R","volume":"10","author":"RA Nagel","year":"1990","unstructured":"Nagel RA, Dirix LY, Hayllar KM, Preisig R, Tredger JM, Williams R (1990) Use of quantitative liver function tests-caffeine clearance and galactose elimination capacity-after orthotopic liver transplantation. J Hepatol 10(2):149\u2013157","journal-title":"J Hepatol"},{"issue":"3","key":"3_CR219_3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1248\/bpb1978.8.151","volume":"8","author":"K Nakazawa","year":"1985","unstructured":"Nakazawa K, Tanaka H, Arima M (1985) The effect of caffeine ingestion on pharmacokinetics of caffeine and its metabolites after a single administration in pregnant rats. J Pharmacobiodyn 8(3):151\u2013160","journal-title":"J Pharmacobiodyn"},{"issue":"4","key":"3_CR220_3","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/BF02976193","volume":"20","author":"BH Nam","year":"1997","unstructured":"Nam BH, Sohn DH, Ko G, Kim JB (1997) Effect of hepatic cirrhosis on the pharmacokinetics of theophylline in rats. Arch Pharm Res 20(4):318\u2013323","journal-title":"Arch Pharm Res"},{"issue":"1","key":"3_CR221_3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/BF00609587","volume":"21","author":"R Newton","year":"1981","unstructured":"Newton R, Broughton LJ, Lind MJ, Morrisson PJ, Rogers HJ, Bradbrook ID (1981) Plasma and salivary pharmacokinetics of caffeine in man. Eur J Clin Pharmacol 21(1):45\u201352","journal-title":"Eur J Clin Pharmacol"},{"key":"3_CR222_3","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S0009-9236(03)00013-4","volume":"73","author":"Y Obase","year":"2003","unstructured":"Obase Y, Shimoda T, Kawano T, Saeki S, Tomari S, Matsuse H, Kinoshita M, Kohno S (2003) Polymorphisms in the CYP1A2 gene and metabolism in patients with asthma. Clin Pharmacol Ther 73:468\u2013474","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"3_CR223_3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2165\/00003088-197803040-00002","volume":"3","author":"RI Ogilvie","year":"1978","unstructured":"Ogilvie RI (1978) Clinical pharmacokinetics of theophylline. Clin Pharmacokinet 3(4):267\u2013293","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"3_CR224_3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/clpt.1991.120","volume":"50","author":"AH Oliveto","year":"1991","unstructured":"Oliveto AH, Hughes JR, Terry SY, Bickel WK, Higgins ST, Pepper SL, Fenwick JW (1991) Effects of caffeine on tobacco withdrawal. Clin Pharmacol Ther 50(2):157\u2013164","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"3_CR225_3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0160-5402(91)90026-2","volume":"25","author":"D Omarini","year":"1991","unstructured":"Omarini D, Barzago MM, Bortolotti A, Aramayona J, Bonati M (1991) Placental transfer of theophylline during in situ perfusion in the rabbit. J Pharmacol Methods 25(4):263\u2013273","journal-title":"J Pharmacol Methods"},{"issue":"2","key":"3_CR226_3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1046\/j.1365-2125.2000.00128.x","volume":"49","author":"DS Ou-Yang","year":"2000","unstructured":"Ou-Yang DS, Huang SL, Wang W, Xie HG, Xu ZH, Shu Y, Zhou HH (2000) Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population. Br J Clin Pharmacol 49(2):145\u2013151","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"3_CR227_3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1046\/j.1365-2036.2000.00703.x","volume":"14","author":"WJ Pan","year":"2000","unstructured":"Pan WJ, Goldwater DR, Zhang Y, Pilmer BL, Hunt RH (2000) Lack of a pharmacokinetic interaction between lansoprazole or pantoprazole and theophylline. Aliment Pharmacol Ther 14(3):345\u2013352","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"3_CR228_3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/BF02976437","volume":"22","author":"EJ Park","year":"1999","unstructured":"Park EJ, Ko G, Kim J, Sohn DH (1999) Biotransformation of theophylline in cirrhotic rats induced by biliary obstruction. Arch Pharm Res 22(1):60\u201367","journal-title":"Arch Pharm Res"},{"issue":"5","key":"3_CR229_3","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1053\/jhep.2003.50475","volume":"38","author":"GJ Park","year":"2003","unstructured":"Park GJ, Katelaris PH, Jones DB, Seow F, Le Couteur DG, Ngu MC (2003) Validity of the 13C-caffeine breath test as a noninvasive, quantitative test of liver function. Hepatology 38(5):1227\u20131236","journal-title":"Hepatology"},{"issue":"1","key":"3_CR230_3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0378-4347(91)80214-W","volume":"570","author":"P Parra","year":"1991","unstructured":"Parra P, Limon A, Ferre S, Guix T, Jane F (1991) High-performance liquid chromatographic separation of caffeine, theophylline, theobromine and paraxanthine in rat brain and serum. J Chromatogr 570(1):185\u2013190","journal-title":"J Chromatogr"},{"issue":"1","key":"3_CR231_3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/cpt197824140","volume":"24","author":"W Parsons","year":"1978","unstructured":"Parsons W, Neims A (1978) Effect of smoking on caffeine clearance. Clin Pharmacol Ther 24(1):40\u201345","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"3_CR232_3","first-page":"603","volume":"95","author":"R Patwardhan","year":"1980","unstructured":"Patwardhan R, Desmond P, Johnson R, Schenker S (1980) Impaired elimination of caffeine by oral contraceptive steroid. J Lab Clin Med 95(4):603\u2013608","journal-title":"J Lab Clin Med"},{"issue":"3","key":"3_CR233_3","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/jps.2600730310","volume":"73","author":"DF Perry","year":"1984","unstructured":"Perry DF, Walson PD, Blanchard J (1984) Effect of pH on theophylline transfer across the everted rat jejunum. J Pharm Sci 73(3):320\u2013325","journal-title":"J Pharm Sci"},{"issue":"6","key":"3_CR234_3","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1203\/00006450-198806000-00021","volume":"23","author":"G Pons","year":"1988","unstructured":"Pons G, Blais J-C, Rey E, Plissonnier M, Richard M-O, Carrier O, D'Athis P, Moran Badoual J, Olive G (1988) Maturation of caffeine N-demethylation in infancy: a study using the 13CO2 breath test. Pediatr Res 23(6):632\u2013636","journal-title":"Pediatr Res"},{"issue":"1","key":"3_CR235_3","first-page":"17","volume":"116","author":"JR Powell","year":"1977","unstructured":"Powell JR, Thiercelin JF, Vozeh S, Sansom L, Riegelman S (1977) The influence of cigarette smoking and sex on theophylline disposition. Am Rev Respir Dis 116(1):17\u201323","journal-title":"Am Rev Respir Dis"},{"key":"3_CR236_3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00008571-200208000-00008","volume":"12","author":"BB Rasmussen","year":"2002","unstructured":"Rasmussen BB, Brix TH, Kyvik KO, Br\u00f8sen K (2002) The differences in the 3-demethylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors. Pharmacogenetics 12:473\u2013478","journal-title":"Pharmacogenetics"},{"issue":"1","key":"3_CR237_3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/hep.1840040107","volume":"4","author":"E Renner","year":"1984","unstructured":"Renner E, Wietholtz H, Huguenin P, Arnaud MJ, Preisig R (1984) Caffeine: a model compound for measuring liver function. Hepatology 4(1):38\u201346","journal-title":"Hepatology"},{"issue":"3","key":"3_CR238_3","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0022-3476(77)81329-2","volume":"91","author":"BH Resman","year":"1977","unstructured":"Resman BH, Blumenthal P, Jusko WJ (1977) Breast milk distribution of theobromine from chocolate. J Pediatr 91(3):477\u2013480","journal-title":"J Pediatr"},{"issue":"3","key":"3_CR239_3","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/BF00548769","volume":"26","author":"EC Rietveld","year":"1984","unstructured":"Rietveld EC, Broekman MM, Houben JJ, Eskes TK, van Rossum JM (1984) Rapid onset of an increase in caffeine residence time in young women due to oral contraceptive steroids. Eur J Clin Pharmacol 26(3):371\u2013373","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"3_CR240_3","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/0006-2952(88)90423-6","volume":"37","author":"RA Robson","year":"1988","unstructured":"Robson RA, Miners JO, Matthews AP, Stupans I, Meller D, McManus ME, Birkett DJ (1988) Characterisation of theophylline metabolism by human liver microsomes. Inhibition and immunochemical studies. Biochem Pharmacol 37(9):1651\u20131659","journal-title":"Biochem Pharmacol"},{"issue":"4A","key":"3_CR241_3","doi-asserted-by":"crossref","first-page":"22S","DOI":"10.1016\/0002-9343(92)90303-S","volume":"92","author":"RA Robson","year":"1992","unstructured":"Robson RA (1992) The effects of quinolones on xanthine pharmacokinetics. Am J Med 92(4A):22S\u201325S","journal-title":"Am J Med"},{"issue":"3","key":"3_CR242_3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3109\/00365519609088615","volume":"56","author":"N Rodopoulos","year":"1996","unstructured":"Rodopoulos N, Norman A (1996) Assessment of dimethylxanthine formation from caffeine in healthy adults: comparison between plasma and saliva concentrations and urinary excretion of metabolites. Scand J Clin Lab Invest 56(3):259\u2013268","journal-title":"Scand J Clin Lab Invest"},{"issue":"4","key":"3_CR243_3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3109\/00365519609090590","volume":"56","author":"N Rodopoulos","year":"1996","unstructured":"Rodopoulos N, H\u00f6jvall L, Norman A (1996) Elimination of theobromine metabolites in healthy adults. Scand J Clin Lab Invest 56(4):373\u2013383","journal-title":"Scand J Clin Lab Invest"},{"issue":"3","key":"3_CR244_3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3109\/00365519709060032","volume":"57","author":"N Rodopoulos","year":"1997","unstructured":"Rodopoulos N, Norman A (1997) Elimination of theophylline metabolites in healthy adults. Scand J Clin Lab Invest 57(3):233\u2013240","journal-title":"Scand J Clin Lab Invest"},{"issue":"2","key":"3_CR245_3","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.watres.2009.07.004","volume":"44","author":"R Rosal","year":"2010","unstructured":"Rosal R, Rodr\u00edguez A, Perdig\u00f3n-Mel\u00f3n JA, Petre A, Garc\u00eda-Calvo E, G\u00f3mez MJ, Ag\u00fcera A, Fern\u00e1ndez-Alba AR (2010) Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation. Water Res 44(2):578\u2013588","journal-title":"Water Res"},{"issue":"4","key":"3_CR246_3","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/clpt.1994.49","volume":"55","author":"KL Rost","year":"1994","unstructured":"Rost KL, Roots I (1994) Accelerated caffeine metabolism after omeprazole treatment is indicated by urinary metabolite ratios: coincidence with plasma clearance and breath test. Clin Pharmacol Ther 55(4):402\u2013411","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"3_CR247_3","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/sj.clpt.6100187","volume":"82","author":"JY Ryu","year":"2007","unstructured":"Ryu JY, Song IS, Sunwoo YE, Shon JH, Liu KH, Cha IJ, Shin JG (2007) Development of the \u201cInje cocktail\u201d for high-throughput evaluation of five human cytochrome P450 isoforms in vivo. Clin Pharmacol Ther 82(5):531\u2013540","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"3_CR248_3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/sj.jcbfm.9600539","volume":"28","author":"KT Sachse","year":"2008","unstructured":"Sachse KT, Jackson EK, Wisniewski SR, Gillespie DG, Puccio AM, Clark RS, Dixon CE, Kochanek PM (2008) Increases in cerebrospinal fluid caffeine concentration are associated with favorable outcome after severe traumatic brain injury in humans. J Cereb Blood Flow Metab 28(2):395\u2013401","journal-title":"J Cereb Blood Flow Metab"},{"key":"3_CR249_3","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1002\/cber.188501802316","volume":"18","author":"G Salomon","year":"1883","unstructured":"Salomon G (1883) \u00dcber Paraxanthine und Heteroxanthin. Ber Dtsch Chem Ges 18:3406\u20133410","journal-title":"Ber Dtsch Chem Ges"},{"issue":"1","key":"3_CR250_3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0090-9556(25)08515-0","volume":"20","author":"MA Sarkar","year":"1992","unstructured":"Sarkar MA, Hunt C, Guzelian PS, Karnes HT (1992) Characterization of human liver cytochromes P-450 involved in theophylline metabolism. Drug Metab Dispos 20(1):31\u201337","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"3_CR251_3","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0090-9556(25)08424-7","volume":"22","author":"MA Sarkar","year":"1994","unstructured":"Sarkar MA, Jackson BJ (1994) Theophylline N-demethylations as probes for P4501A1 and P4501A2. Drug Metab Dispos 22(6):827\u2013834","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"3_CR252_3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1067\/mcp.2002.126173","volume":"72","author":"J Saruwatari","year":"2002","unstructured":"Saruwatari J, Nakagawa K, Shindo J, Tajiri T, Fujieda M, Yamazaki H, Kamataki T, Ishizaki T (2002) A population phenotyping study of three drug-metabolizing enzymes in Kyushu, Japan, with use of the caffeine test. Clin Pharmacol Ther 72(2):200\u2013208","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"3_CR253_3","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/BF00271376","volume":"44","author":"J Sato","year":"1993","unstructured":"Sato J, Nakata H, Owada E, Kikuta T, Umetsu M, Ito K (1993) Influence of usual intake of dietary caffeine on single-dose kinetics of theophylline in healthy human subjects. Eur J Clin Pharmacol 44(3):295\u2013298","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"3_CR254_3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2133\/dmpk.22.169","volume":"22","author":"S Sato","year":"2007","unstructured":"Sato S, Nakajima M, Honda A, Konishi T, Miyazaki H (2007) Pharmacokinetics of theophylline in Guinea pig tears. Drug Metab Pharmacokinet 22(3):169\u2013177","journal-title":"Drug Metab Pharmacokinet"},{"issue":"1","key":"3_CR255_3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/0168-8278(95)80264-9","volume":"22","author":"HJ Schaad","year":"1995","unstructured":"Schaad HJ, Renner EL, Wietholtz H, Arnaud MJ, Preisig R (1995) Caffeine demethylation measured by breath analysis in experimental liver injury in the rat. J Hepatol 22(1):82\u201387","journal-title":"J Hepatol"},{"issue":"4","key":"3_CR256_3","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1159\/000194651","volume":"45","author":"F Schlaeffer","year":"1984","unstructured":"Schlaeffer F, Engelberg I, Kaplanski J, Danon A (1984) Effect of exercise and environmental heat on theophylline kinetics. Respiration 45(4):438\u2013442","journal-title":"Respiration"},{"issue":"6","key":"3_CR257_3","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/00008571-199912000-00007","volume":"9","author":"J Schmider","year":"1999","unstructured":"Schmider J, Brockm\u00f6ller J, Arold G, Bauer S, Roots I (1999) Simultaneous assessment of CYP3A4 and CYP1A2 activity in vivo with alprazolam and caffeine. Pharmacogenetics 9(6):725\u2013734","journal-title":"Pharmacogenetics"},{"issue":"8","key":"3_CR258_3","first-page":"1155","volume":"5","author":"D Schrenk","year":"1998","unstructured":"Schrenk D (1998) Impact of dioxin-type induction of drug-metabolizing enzymes on the metabolism of endo- and xenobiotics. Biochem Pharmacol 5(8):1155\u20131162","journal-title":"Biochem Pharmacol"},{"issue":"Pt 2","key":"3_CR259_3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/000456328402100208","volume":"21","author":"NR Scott","year":"1984","unstructured":"Scott NR, Chakraborty J, Marks V (1984) Determination of caffeine, theophylline and theobromine in serum and saliva using high-performance liquid chromatography. Ann Clin Biochem 21(Pt 2):120\u2013124","journal-title":"Ann Clin Biochem"},{"issue":"4","key":"3_CR260_3","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1365-2125.1986.tb02920.x","volume":"22","author":"NR Scott","year":"1986","unstructured":"Scott NR, Chakraborty J, Marks V (1986) Urinary metabolites of caffeine in pregnant women. Br J Clin Pharmacol 22(4):475\u2013478","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"3_CR261_3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1042\/cs0740377","volume":"74","author":"NR Scott","year":"1988","unstructured":"Scott NR, Stambuk D, Chakraborty J, Marks V, Morgan MY (1988) Caffeine clearance and biotransformation in patients with chronic liver disease. Clin Sci 74(4):377\u2013384","journal-title":"Clin Sci"},{"issue":"2","key":"3_CR262_3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1365-2125.1989.tb05352.x","volume":"27","author":"NR Scott","year":"1989","unstructured":"Scott NR, Stambuk D, Chakraborty J, Marks V, Morgan MY (1989) The pharmacokinetics of caffeine and its dimethylxanthine metabolites in patients with chronic liver disease. Br J Clin Pharmacol 27(2):205\u2013213","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"3_CR263_3","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/clpt.1982.193","volume":"32","author":"LM Shaw","year":"1982","unstructured":"Shaw LM, Fields L, Mayock R (1982) Factors influencing theophylline serum protein binding. Clin Pharmacol Ther 32(4):490\u2013496","journal-title":"Clin Pharmacol Ther"},{"key":"3_CR264_3","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0022-3565(25)22379-5","volume":"270","author":"T Shimada","year":"1994","unstructured":"Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP (1994) Interindividual variations in human liver cytochrome P- 450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414\u2013423","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"3_CR265_3","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/0041-008X(83)90321-6","volume":"67","author":"CA Shively","year":"1983","unstructured":"Shively CA, Tarka SM Jr (1983) Theobromine metabolism and pharmacokinetics in pregnant and nonpregnant Sprague-Dawley rats. Toxicol Appl Pharmacol 67(3):376\u2013382","journal-title":"Toxicol Appl Pharmacol"},{"key":"3_CR266_3","first-page":"149","volume-title":"Methylxanthine composition and consumption patterns of cocoa and chocolate products. In: Spiller GA (ed) The methylxanthine beverages in foods: chemistry, consumption, and health effects","author":"CA Shively","year":"1984","unstructured":"Shively CA, Tarka SM Jr (1984) Methylxanthine composition and consumption patterns of cocoa and chocolate products. In: Spiller GA (ed) The methylxanthine beverages in foods: chemistry, consumption, and health effects. Alan R Liss, New York, pp 149\u2013178"},{"issue":"4","key":"3_CR267_3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/clpt.1985.65","volume":"37","author":"CA Shively","year":"1985","unstructured":"Shively CA, Tarka SM Jr, Arnaud MJ, Dvorchik BH, Passananti GT, Vesell ES (1985) High levels of methylxanthines in chocolate do not alter theobromine disposition. Clin Pharmacol Ther 37(4):415\u2013424","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"3_CR268_3","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/00007691-199009000-00009","volume":"12","author":"IA Siegel","year":"1990","unstructured":"Siegel IA, Ben-Aryeh H, Gozal D, Colin AA, Szargel R, Laufer D (1990) Comparison of unbound and total serum theophylline concentrations with those of stimulated and unstimulated saliva in asthmatic children. Ther Drug Monit 12(5):460\u2013464","journal-title":"Ther Drug Monit"},{"issue":"4","key":"3_CR269_3","first-page":"337","volume":"5","author":"FE Simons","year":"1981","unstructured":"Simons FE, Rigatto H, Simons KJ (1981) Pharmacokinetics of theophylline in neonates. Semin Perinatol 5(4):337\u2013345","journal-title":"Semin Perinatol"},{"issue":"12","key":"3_CR270_3","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1023\/A:1015816509140","volume":"9","author":"P Sj\u00f6berg","year":"1992","unstructured":"Sj\u00f6berg P, Olofsson IM, Lundqvist T (1992) Validation of different microdialysis methods for the determination of unbound steady-state concentrations of theophylline in blood and brain tissue. Pharm Res 9(12):1592\u20131598","journal-title":"Pharm Res"},{"issue":"4","key":"3_CR271_3","first-page":"332","volume":"5","author":"LF Soyka","year":"1981","unstructured":"Soyka LF, Neese AL, Main D, Main E (1981) Studies of caffeine and theophylline in the neonate. Semin Perinatol 5(4):332\u2013336","journal-title":"Semin Perinatol"},{"issue":"6","key":"3_CR272_3","doi-asserted-by":"publisher","first-page":"460","DOI":"10.2165\/00002018-199106060-00006","volume":"6","author":"AD Sperber","year":"1991","unstructured":"Sperber AD (1991) Toxic interaction between fluvoxamine and sustained release theophylline in an 11-year-old boy. Drug Saf 6(6):460\u2013462","journal-title":"Drug Saf"},{"issue":"3","key":"3_CR273_3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/00008571-199906000-00019","volume":"9","author":"O Spigset","year":"1999","unstructured":"Spigset O, H\u00e4gg S, S\u00f6derstr\u00f6m E, Dahlqvist R (1999a) The paraxanthine:caffeine ratio in serum or in saliva as a measure of CYP1A2 activity: when should the sample be obtained? Pharmacogenetics 9(3):409\u2013412","journal-title":"Pharmacogenetics"},{"issue":"12","key":"3_CR274_3","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s002280050579","volume":"54","author":"O Spigset","year":"1999","unstructured":"Spigset O, H\u00e4gg S, S\u00f6derstr\u00f6m E, Dahlqvist R (1999b) Lack of correlation between fluvoxamine clearance and CYP1A2 activity as measured by systemic caffeine clearance. Eur J Clin Pharmacol 54(12):943\u2013946","journal-title":"Eur J Clin Pharmacol"},{"issue":"24","key":"3_CR275_3","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/0024-3205(91)90486-U","volume":"49","author":"L St\u00e5hle","year":"1991","unstructured":"St\u00e5hle L (1991) Drug distribution studies with microdialysis: I. Tissue dependent difference in recovery between caffeine and theophylline. Life Sci 49(24):1835\u20131842","journal-title":"Life Sci"},{"issue":"24","key":"3_CR276_3","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/0024-3205(91)90487-V","volume":"49","author":"L St\u00e5hle","year":"1991","unstructured":"St\u00e5hle L, Segersv\u00e4rd S, Ungerstedt U (1991) Drug distribution studies with microdialysis. II. Caffeine and theophylline in blood, brain and other tissues in rats. Life Sci 49(24):1843\u20131852","journal-title":"Life Sci"},{"issue":"3","key":"3_CR277_3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/ajcp\/73.3.390","volume":"73","author":"BE Statland","year":"1980","unstructured":"Statland BE, Demas TJ (1980) Serum caffeine half-lives. Healthy subjects vs. patients having alcoholic hepatic disease. Am J Clin Pathol 73(3):90\u2013393","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"3_CR278_3","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1177\/0091270006288955","volume":"46","author":"RJ Straka","year":"2006","unstructured":"Straka RJ, Burkhardt RT, Lang NP, Hadsall KZ, Tsai MY (2006) Discordance between N-acetyltransferase 2 phenotype and genotype in a population of Hmong subjects. J Clin Pharmacol 46(7):802\u201311","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"3_CR279_3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1067\/mcp.2000.109519","volume":"68","author":"DS Streetman","year":"2000","unstructured":"Streetman DS, Bleakley JF, Kim JS, Nafziger AN, Leeder JS, Gaedigk A, Gotschall R, Kearns GL, Bertino JS Jr (2000) Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the \u201cCooperstown cocktail\u201d. Clin Pharmacol Ther 68(4):375\u2013383","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"3_CR280_3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00228-005-0057-z","volume":"62","author":"K Takata","year":"2006","unstructured":"Takata K, Saruwatari J, Nakada N, Nakagawa M, Fukuda K, Tanaka F, Takenaka S, Mihara S (2006) Phenotype-genotype analysis of CYP1A2 in Japanese patients receiving oral theophylline therapy. Eur J Clin Pharmacol 62(1):23\u201328","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"3_CR281_3","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3109\/00498259209053116","volume":"22","author":"E Tanaka","year":"1992","unstructured":"Tanaka E, Ishikawa A, Yamamoto Y, Uchida E, Kobayashi S, Yasuhara H, Misawa S (1992a) Simplified approach for evaluation of hepatic drug-oxidizing capacity with a simultaneous measurement of caffeine and its primary demethylated metabolites in carbon tetrachloride-intoxicated rats. Xenobiotica 22(5):535\u2013541","journal-title":"Xenobiotica"},{"issue":"9","key":"3_CR282_3","first-page":"336","volume":"30","author":"E Tanaka","year":"1992","unstructured":"Tanaka E, Ishikawa A, Yamamoto Y, Osada A, Tsuji K, Fukao K, Misawa S, Iwasaki Y (1992b) A simple useful method for the determination of hepatic function in patients with liver cirrhosis using caffeine and its three major dimethylmetabolites. Int J Clin Pharmacol Ther Toxicol 30(9):336\u2013341","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"issue":"1","key":"3_CR283_3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1600-0773.1993.tb01335.x","volume":"72","author":"E Tanaka","year":"1993","unstructured":"Tanaka E, Ishikawa A, Yamamoto Y, Osada A, Tsuji K, Fukao K, Iwasaki Y (1993) Comparison of hepatic drug-oxidizing activity after simultaneous administration of two probe drugs, caffeine and trimethadione, to human subjects. Pharmacol Toxicol 72(1):31\u201333","journal-title":"Pharmacol Toxicol"},{"issue":"10","key":"3_CR284_3","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.3109\/00498259509061911","volume":"25","author":"E Tanaka","year":"1995","unstructured":"Tanaka E, Ishikawa A, Misawa S (1995) Changes in the metabolism of three model substrates catalysed by different P isozymes when administered as a cocktail to the carbon tetrachloride-intoxicated rat. Xenobiotica 25(10):1111\u20131118","journal-title":"Xenobiotica"},{"issue":"3","key":"3_CR285_3","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0090-9556(25)08007-9","volume":"11","author":"BK Tang","year":"1983","unstructured":"Tang BK, Grant DM, Kalow W (1983) Isolation and identification of 5-acetylamino-6-formylamino-3-methyluracil as a major metabolite of caffeine in man. Drug Metab Dispos 11(3):218\u2013220","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"3_CR286_3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0378-4347(00)83706-8","volume":"375","author":"BK Tang","year":"1986","unstructured":"Tang BK, Zubovits T, Kalow W (1986) Determination of acetylated caffeine by high-performance exclusion chromatography. J Chromatogr 375(1):170\u2013173","journal-title":"J Chromatogr"},{"issue":"3","key":"3_CR287_3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/00008571-199406000-00002","volume":"4","author":"BK Tang","year":"1994","unstructured":"Tang BK, Zhou Y, Kadar D, Kalow W (1994) Caffeine as a probe for CYP1A2 activity: potential influence of renal factors on urinary phenotypic trait measurements. Pharmacogenetics 4(3):117\u2013224","journal-title":"Pharmacogenetics"},{"issue":"3","key":"3_CR288_3","first-page":"371","volume":"34","author":"DD Tang-Liu","year":"1981","unstructured":"Tang-Liu DD, Riegelman S (1981) Metabolism of theophylline to caffeine in adults. Res Commun Chem Pathol Pharmacol 34(3):371\u2013380","journal-title":"Res Commun Chem Pathol Pharmacol"},{"issue":"1","key":"3_CR289_3","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-3565(25)33447-6","volume":"224","author":"DDS Tang-Liu","year":"1983","unstructured":"Tang-Liu DDS, Williams RL, Reigelman S (1983) Disposition of caffeine and its metabolites in man. J Pharmacol Exp Ther 224(1):180\u2013185","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"3_CR290_3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3109\/10408448209037495","volume":"9","author":"SM Tarka Jr","year":"1982","unstructured":"Tarka SM Jr (1982) The toxicology of cocoa and methylxanthines: a review of the literature. Crit Rev Toxicol 9(4):275\u2013312","journal-title":"Crit Rev Toxicol"},{"issue":"4","key":"3_CR291_3","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/clpt.1983.212","volume":"34","author":"SM Tarka Jr","year":"1983","unstructured":"Tarka SM Jr, Arnaud MJ, Dvorchik BH, Vesell ES (1983) Theobromine kinetics and metabolic disposition. Clin Pharmacol Ther 34(4):546\u2013555","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"3_CR292_3","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/0006-2952(94)90304-2","volume":"47","author":"W Tassaneeyakul","year":"1994","unstructured":"Tassaneeyakul W, Birkett DJ, McManus ME, Tassaneeyakul W, Veronese ME, Andersson T, Tukey RH, Miners JO (1994) Caffeine metabolism by human hepatic cytochromes P450: contributions of 1A2, 2E1 and 3A isoforms. Biochem Pharmacol 47(10):1767\u20131776","journal-title":"Biochem Pharmacol"},{"issue":"6 Pt 2","key":"3_CR293_3","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1016\/0002-9378(90)90563-M","volume":"163","author":"AT Teichmann","year":"1990","unstructured":"Teichmann AT (1990) Influence of oral contraceptives on drug therapy. Am J Obstet Gynecol 163(6 Pt 2):2208\u20132213","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"3_CR294_3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3109\/00498258509045346","volume":"15","author":"MW Teunissen","year":"1985","unstructured":"Teunissen MW, Brorens IO, Geerlings JM, Breimer DD (1985) Dose-dependent elimination of theophylline in rats. Xenobiotica 15(2):165\u2013171","journal-title":"Xenobiotica"},{"issue":"2","key":"3_CR295_3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/BF00545966","volume":"23","author":"KM Tornatore","year":"1982","unstructured":"Tornatore KM, Kanarkowski R, McCarthy TL, Gardner MJ, Yurchak AM, Jusko WJ (1982) Effect of chronic oral contraceptive steroids on theophylline disposition. Eur J Clin Pharmacol 23(2):129\u2013134","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"3_CR296_3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/bdd.2510060107","volume":"6","author":"JM Trang","year":"1985","unstructured":"Trang JM, Blanchard J, Conrad KA, Harrison GG (1985) Relationship between total body clearance of caffeine and urine flow rate in elderly men. Biopharm Drug Dispos 6(1):51\u201356","journal-title":"Biopharm Drug Dispos"},{"issue":"2 Pt 1","key":"3_CR297_3","first-page":"166","volume":"40","author":"Z Trnavsk\u00e1","year":"1990","unstructured":"Trnavsk\u00e1 Z (1990) Theophylline protein binding. Arzneimittelforschung 40(2 Pt 1):166\u2013169","journal-title":"Arzneimittelforschung"},{"issue":"4","key":"3_CR298_3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2165\/00003088-199528040-00003","volume":"28","author":"U Tr\u00f6ger","year":"1995","unstructured":"Tr\u00f6ger U, Meyer FP (1995) Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline focus on biotransformation. Clin Pharmacokinet 28(4):287\u2013314","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"3_CR299_3","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/clpt.1983.71","volume":"33","author":"KY Tserng","year":"1983","unstructured":"Tserng KY, Takieddine FN, King KC (1983) Developmental aspects of theophylline metabolism in premature infants. Clin Pharmacol Ther 33(4):522\u2013528","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"3_CR300_3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1067\/mcp.2001.116495","volume":"70","author":"K Tsutsumi","year":"2001","unstructured":"Tsutsumi K, Kotegawa T, Matsuki S, Tanaka Y, Ishii Y, Kodama Y, Kuranari M, Miyakawa I, Nakano S (2001) The effect of pregnancy on cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activities in humans. Clin Pharmacol Ther 70(2):121\u2013125","journal-title":"Clin Pharmacol Ther"},{"key":"3_CR301_3","first-page":"66","volume":"3","author":"JJ Tukker","year":"1991","unstructured":"Tukker JJ, Meulendijk AJ (1991) Is a diurnal rhythm in bioavailability caused by a rhythm in intestinal absorption? Eur J Drug Metab Pharmacokinet Spec No 3:66\u201370","journal-title":"Eur J Drug Metab Pharmacokinet Spec No"},{"issue":"1","key":"3_CR302_3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2165\/00003088-199120010-00005","volume":"20","author":"RA Upton","year":"1991","unstructured":"Upton RA (1991) Pharmacokinetic interactions between theophylline and other medication (Part I). Clin Pharmacokinet 20(1):66\u201380","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"3_CR303_3","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1365-2885.2008.00942.x","volume":"31","author":"TW Vickroy","year":"2008","unstructured":"Vickroy TW, Chang SK, Chou CC (2008) Caffeine-induced hyperactivity in the horse: comparisons of drug and metabolite concentrations in blood and cerebrospinal fluid. J Vet Pharmacol Ther 31(2):156\u2013166","journal-title":"J Vet Pharmacol Ther"},{"key":"3_CR304_3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/978-1-4684-5877-0_55","volume":"283","author":"K Vistisen","year":"1991","unstructured":"Vistisen K, Loft S, Poulsen HE (1991) Cytochrome P450 IA2 activity in man measured by caffeine metabolism: effect of smoking, broccoli and exercise. Adv Exp Biol Biol 283:407\u2013411","journal-title":"Adv Exp Biol Biol"},{"issue":"9","key":"3_CR305_3","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/carcin\/13.9.1561","volume":"13","author":"K Vistisen","year":"1992","unstructured":"Vistisen K, Poulsen HE, Loft S (1992) Foreign compound metabolism capacity in man measured from metabolites of dietary caffeine. Carcinogenesis 13(9):1561\u20131568","journal-title":"Carcinogenesis"},{"issue":"7","key":"3_CR306_3","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0278-6915(01)00006-0","volume":"39","author":"K Walton","year":"2001","unstructured":"Walton K, Dorne JL, Renwick AG (2001) Uncertainty factors for chemical risk assessment: interspecies differences in the in vivo pharmacokinetics and metabolism of human CYP1A2 substrates. Food Chem Toxicol 39(7):667\u2013680","journal-title":"Food Chem Toxicol"},{"issue":"3\u20134","key":"3_CR307_3","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000241007","volume":"32","author":"D Warszawski","year":"1977","unstructured":"Warszawski D, Gorodischer R, Moses SW, Bark H (1977) Caffeine pharmacokinetics in young and adult dogs. Biol Neonate 32(3\u20134):138\u2013142","journal-title":"Biol Neonate"},{"issue":"4","key":"3_CR308_3","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0090-9556(25)07907-3","volume":"10","author":"D Warszawski","year":"1982","unstructured":"Warszawski D, Ben-Zvi Z, Gorodischer R, Arnaud MJ, Bracco I (1982) Urinary metabolites of caffeine in young dogs. Drug Metab Dispos 10(4):424\u2013428","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"3_CR309_3","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S0022-3476(77)81051-2","volume":"91","author":"M Weinberger","year":"1977","unstructured":"Weinberger M, Ginchansky E (1977) Dose-dependent kinetics of theophylline disposition in asthmatic children. J Pediatr 91(5):820\u2013824","journal-title":"J Pediatr"},{"issue":"1","key":"3_CR310_3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/BF00609588","volume":"21","author":"H Wietholtz","year":"1981","unstructured":"Wietholtz H, Voegelin M, Arnaud MJ, Bircher J, Preisig R (1981) Assessment of cytochrome P-448 dependent liver enzyme system by a caffeine breath test. Eur J Clin Pharmacol 21(1):53\u201359","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"3_CR312_3","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1378\/chest.98.6.1440","volume":"98","author":"GJ Wijnands","year":"1990","unstructured":"Wijnands GJ, Cornel JH, Martea M, Vree TB (1990) The effect of multiple-dose oral lomefloxacin on theophylline metabolism in man. Chest 98(6):1440\u20131444","journal-title":"Chest"},{"issue":"2","key":"3_CR313_3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-3806(93)90023-4","volume":"75","author":"JM Wilkinson","year":"1993","unstructured":"Wilkinson JM, Pollard I (1993) Accumulation of theophylline, theobromine and paraxanthine in the fetal rat brain following a single oral dose of caffeine. Brain Res Dev Brain Res 75(2):193\u2013199","journal-title":"Brain Res Dev Brain Res"},{"issue":"14","key":"3_CR314_3","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1016\/j.watres.2009.05.014","volume":"43","author":"C Wu","year":"2009","unstructured":"Wu C, Witter JD, Spongberg AL, Czajkowski KP (2009) Occurrence of selected pharmaceuticals in an agricultural landscape, western Lake Erie basin. Water Res 43(14):3407\u2013416","journal-title":"Water Res"},{"issue":"2","key":"3_CR315_3","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/sj.bjp.0706319","volume":"146","author":"H Xu","year":"2005","unstructured":"Xu H, Rajesan R, Harper P, Kim RB, Lonnerdal B, Yang M, Uematsu S, Hutson J, Watson-MacDonell J, Ito S (2005) Induction of P 1A by cow milk-based formula: a comparative study between human milk and formula. Br J Pharmacol 146(2):296\u2013305","journal-title":"Br J Pharmacol"},{"issue":"1","key":"3_CR316_3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1211\/jpp.60.1.0006","volume":"60","author":"KH Yang","year":"2008","unstructured":"Yang KH, Lee JH, Lee MG (2008) Effects of CYP inducers and inhibitors on the pharmacokinetics of intravenous theophylline in rats: involvement of CYP1A1\/2 in the formation of 1,3-DMU. J Pharm Pharmacol 60(1):45\u201353","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"3_CR317_3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1248\/bpb.16.59","volume":"16","author":"I Yano","year":"1993","unstructured":"Yano I, Tanigawara Y, Yasuhara M, Mikawa H, Hori R (1993) Population pharmacokinetics of theophylline. I: Intravenous infusion to children in the acute episode of asthma. Biol Pharm Bull 16(1):59\u201362","journal-title":"Biol Pharm Bull"},{"key":"3_CR318_3","first-page":"215","volume":"158","author":"DW Yesair","year":"1984","unstructured":"Yesair DW, Branfman AR, Callahan MM (1984) Human disposition and some biochemical aspects of methylxanthines. Prog Clin Biol Res 158:215\u2013233","journal-title":"Prog Clin Biol Res"},{"issue":"1","key":"3_CR319_3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1742-7843.2005.pto960111.x","volume":"96","author":"AS Zandvliet","year":"2005","unstructured":"Zandvliet AS, Huitema AD, de Jonge ME, den Hoed R, Sparidans RW, Hendriks VM, van den Brink W, van Ree JM, Beijnen JH (2005) Population pharmacokinetics of caffeine and its metabolites theobromine, paraxanthine and theophylline after inhalation in combination with diacetylmorphine. Basic Clin Pharmacol Toxicol 96(1):71\u201379","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"6","key":"3_CR320_3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2165\/00003088-199936060-00004","volume":"36","author":"S Zevin","year":"1999","unstructured":"Zevin S, Benowitz NL (1999) Drug interactions with tobacco smoking. An update. Clin Pharmacokinet 36(6):425\u2013438","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"3_CR321_3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0006-2952(95)00120-O","volume":"50","author":"Z-Y Zhang","year":"1995","unstructured":"Zhang Z-Y, Kaminsky LS (1995) Characterization of human cytochromes P450 involved in theophylline 8-hydroxylation. Biochem Pharmacol 50(2):205\u2013211","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"3_CR322_3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1067\/mcp.2001.119813","volume":"70","author":"B Zhu","year":"2001","unstructured":"Zhu B, Ou-Yang DS, Chen XP, Huang SL, Tan ZR, He N, Zhou HH (2001) Assessment of cytochrome P450 activity by a five-drug cocktail approach. Clin Pharmacol Ther 70(5):455\u2013461","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"3_CR323_3","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/BF00626367","volume":"41","author":"T Zysset","year":"1991","unstructured":"Zysset T, Wietholtz H (1991) Pharmacokinetics of caffeine in patients with decompensated type I and type II diabetes mellitus. Eur J Clin Pharmacol 41(5):449\u2013452","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Handbook of Experimental Pharmacology","Methylxanthines"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-13443-2_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T18:41:41Z","timestamp":1740508901000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-13443-2_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,19]]},"ISBN":["9783642134425","9783642134432"],"references-count":320,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-13443-2_3","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-642-13443-2","asserted-by":"object"}]},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,19]]}}}